Director, Advanced Heart Failure & Cardiac Transplantation at Mount Sinai Medical Center, NYC, USA
Director, Advanced Heart Failure & Cardiac Transplantation at Mount Sinai Medical Center, NYC, USA
Sean Pinney is a native of St. Louis, Missouri. He attended Georgetown University where he received both his undergraduate and medical degrees. He completed residency training at Boston’s Beth Israel Deaconess Medical Center and fellowships in cardiology, heart failure & transplantation at Columbia University. In 2004, he joined the faculty of the Icahn School of Medicine at Mount Sinai where he has directed the Advanced Heart Failure & Cardiac Transplant Program since 2005. In 2015, he was appointed Director of Heart Failure and Transplantation for the Mount Sinai Health System.
Dr. Pinney is an active clinical researcher who has led both NIH and industry-sponsored trials in the areas of heart failure, cardiac transplantation and mechanical circulatory support.
He serves on the editorial boards of JACC, JACC Heart Failure, the Journal of Heart & Lung Transplantation and the Journal of Cardiac Failure.
CURRICULUM VITAE
Date Prepared: June 11, 2022
Name: Sean Patrick Pinney, M.D., FACC, FAST, FHFSA
Office Address: 5841 S. Maryland Avenue
Rm A621, MC 2016
Chicago, IL 60637
O: (773) 702-9458
Fax: (773) 834-1764
Email: pinneys@medicine.bsd.uchicago.edu
Home Address: 112 Frost Court
Wyckoff, NJ 07481
Place of Birth: St. Louis, Missouri, USA
Date of Birth: July 18, 1968
Education:
1990 B.A. Georgetown University
1994 M.D. Georgetown University School of Medicine
Postdoctoral Training:
1994-1997 Intern and Resident in Medicine, Deaconess Hospital, Boston, MA
1997-1998 Chief Resident in Medicine, Beth Israel Deaconess Medical Center, Boston, MA
1998-2001 Fellow in Cardiovascular Medicine, Columbia Presbyterian Medical Center, New York, NY (Chief Fellow 2000 – 2001)
2001-2002 Congestive Heart Failure & Cardiac Transplant Fellowship, Columbia-Presbyterian Medical Center, New York, NY
Licensure and Certification:
1996 Massachusetts License No. 152309
1997 American Board of Internal Medicine
1998 New York License No. 210926
2001 ABIM Cardiovascular Disease
2005 UNOS Qualified Transplant Cardiologist
2011 ABIM Cardiovascular Disease Recertification
2012 ABIM Advanced Heart Failure/Transplant Cardiology
2020 Illinois License No. 036.153144
Academic Appointments:
1994-1997 Clinical Fellow in Medicine, Harvard Medical School
1997-1998 Instructor in Medicine, Harvard Medical School
1998-2002 Assistant in Clinical Medicine, Columbia University
2002-2004 Instructor of Medicine, Columbia University
2004-2010 Assistant Professor of Medicine, Mount Sinai School of Medicine
2011-2016 Associate Professor of Medicine, Mount Sinai School of Medicine
2017-2020 Professor of Medicine, Icahn School of Medicine at Mount Sinai
2020- Adjunct Professor of Medicine, Icahn School of Medicine at Mount Sinai
2020- Professor of Medicine, University of Chicago Biological Sciences Division
Hospital Appointments:
1998 Physician, Beth Israel Deaconess Medical Center, Boston, Massachusetts
2001-2004 Courtesy Staff, Arden Hill Hospital, Goshen, NY
2002-2004 Assistant Attending Physician, New York Presbyterian Hospital, NY, NY
2004-2020 Attending Physician, Mount Sinai Medical Center, New York, NY
2018-2020 Attending Physician, Mount Sinai St. Luke’s, New York, NY
2020- Attending Physician, University of Chicago Medical Center, Chicago, IL
Major Administrative Responsibilities:
2004-2005 Assistant Director, Cardiac Transplant Program, Mount Sinai Medical Center, New York, NY
2005-2020 Director, Advanced Heart Failure & Cardiac Transplant Program,
Mount Sinai Medical Center, New York, NY
2006-2008 Director, Pulmonary Hypertension Program
Mount Sinai Medical Center, New York, NY
2006-2010 Medical Director, Heart-Lung Transplant Program
Mount Sinai Medical Center New York, NY
2014-2020 Director for Heart Failure and Transplantation
Mount Sinai Health System, New York, NY
2015-2018 Fellowship Director, Advanced Heart Failure & Transplantation
Mount Sinai Hospital, New York, NY
2020- Director, Heart Failure and Cardiac Transplantation
University of Chicago, Chicago, IL
2020- Director, Richard P. Parrillo Family Center for Clinical and Translational Cardiology Research, University of Chicago, Chicago, IL
2020- Co-Director, Heart and Vascular Center
University of Chicago, Chicago, IL
Major Committee Assignments:
American College of Cardiology
2010-2013 Heart Failure and Transplant Committee
2013 ACCF Curriculum Design Work Group
2013-2016 Heart Failure and Transplant Leadership Council
2014-2017 Editorial Team Lead, ACC.org Heart Failure & Cardiomyopathy Clinical
Topic Collection
2015-2016 Editorial Chair, Advanced Heart Failure and Transplant Cardiology Self
Assessment Questions and Board Prep Program
2019- Associate Editor, Heart Failure SAP
American Heart Association
2010-2011 New York Heart Ball Medical Leadership Committee
2018-2020 New York Heart & Stroke Ball Executive Leadership Committee
2018-2020 New York AHA Board of Directors
American Society of Transplantation
2009-2012 Conflict of Interest Committee
2010-2011 Education Committee
2015-2017 Executive committee member, Thoracic and Critical Care Community of
Practice
2020- Board of Directors, member
Beth Israel Deaconess Medical Center
1997-98 Department of Medicine Advisory Committee
1997-98 Department of Medicine Intern Selection Committee
1997-98 Quality Improvement Committee
1997-98 Emergency Unit Committee
1997-98 Medical Library Committee
Columbia-Presbyterian Medical Center
2000-2001 Cardiology Fellowship Committee
2002-2004 Cardiac Transplant Committee
2003-2004 Mechanical Circulatory Support Device Committee
Georgetown University
2020- Medical Alumni Board of Directors
Greater New York Geriatric Cardiology Consortium
2011-2020 Board of Directors
Heart Failure Society of America
2009-2015 Education Committee
2010-2015 CME Subcommittee
2013 Planning committee 2013 HFSA Comprehensive Review and Update
2015-2020 Finance Committee
2015-2020 Publications and Scientific Statements Committee
2016-2017 2017 HFSA Annual Scientific Program Committee member
2017-2018 2018 HFSA Annual Scientific Program Committee member
2019-2020 HFSA Audit Committee
2021- Advocacy Committee
INTERMACS
2014-2018 Data, Access, Analysis, and Publications (DAAP) Committee
2018 – STS Participant User File (PUF) Review Task Force
International Society for Heart and Lung Transplantation
2009-2010 Patient care guidelines taskforce
2013-2017 I2C2 Committee
MCS Committee
Mount Sinai Health System
2014-2020 System-Wide Readmissions Steering Committee
2015 Heart Failure Value Based Purchasing
2015-2017 Quality Leadership Council
2018-2020 MSHS Safe and Timely Discharge Committee
2019-2020 MSHS Care Standardization and Optimization Committees
2019-2020 MSHS Patient Experience Council
Mount Sinai Hospital
2004-2005 Strategic Taskforce for Transplant Services
2004-2006 Quality Improvement Committee for CHF Outcomes
2004-2020 Cardiac Transplant Committee
2004-2014 Academic Mentorship Committee
2005 Search Committee Vice Chair for Clinical Research
2005-2020 CVI Quality Improvement Committee
2005-2020 Transplant Executive Committee
2010-2014 Infection Control Committee
2014-2020 Readmissions Steering Committee, Heart Failure Task Force
2014-2020 Cardiology Clinical Nurse Manager Dyad
2015-2020 Informatics and Big Data Research Group
2015-2020 Reduction in Excess Days (RED) Committee
2018-2020 Physician lead, Patient Experience Committee, Mount Sinai Heart
New York Cardiothoracic Transplant Consortium (NYCTC)
2011-2020 Board of Directors
2011-2013 President
2013-2015 Treasurer
2015-2017 Secretary
2017-2019 Policy oversight committee chair
Live On New York – NY Organ Donor Network (NYODN)
2003-2004 Quality Improvement Subcommittee
2005 Organ Transplant Breakthrough Collaborative
2009-2020 Medical Advisory Board Member
United Network for Organ Sharing (UNOS)
2008-2010 Region 9 Representative, Thoracic Organ Transplantation Committee
Heart Transplant Subcommittee
2010-2012 Membership and Professional Standards Committee
Performance Analysis and Improvement Subcommittee
2016-2018 Membership and Professional Standards Committee, member at-large
2018-2019 OPTN/UNOS Ad Hoc Systems Metrics Working Group
University of Chicago Biological Sciences Division
2021 Search committee member, Cardiac surgery clinical associate
2021-2022 Search committee member, Director Electrophysiology
2021-2022 Search committee member, Director Transplant Nephrology
2021-2022 Co-chair Search committee, Structural heart innovator
Medical Advisory Board
2010-2016 Acorda Thearpeutics, Inc., Hawthorne, NY.
2015-2019 RecoverLink, New York, NY
2018-2020 Procyrion, Inc.
2018- Cordio Medical LTD.
2019- Vascular Dynamics, Inc.
2021- CareDx
2021- Analog Devices Inc.
2022- Recora Health
2022- Ancora
2022- Valgen Medtech
Memberships in Professional Societies:
2004- Fellow, American College of Cardiology
1996-1998 American College of Physicians
Current American Heart Association
1992-1998 American Medical Association
Current Fellow, American Society of Transplantation
Current Fellow, Heart Failure Society of America
Current International Society for Heart and Lung Transplantation
1995-1998 Massachusetts Medical Society
2006-2012 Pulmonary Hypertension Association
Editorial Positions:
2010 – 2017 Case Reports in Transplantation
2014 – 2017 Frontiers in Cardiovascular Medicine
Associate Editor, Heart Failure
2014 – present Journal of the American College of Cardiology
Section editor, Heart Failure
2016 – present Journal of Heart and Lung Transplantation
Editorial Board Consultant
2017 – 2020 Journal of Cardiac Failure, Guest editor
2018 – 2022 JACC Heart Failure, Editorial Consultant
2020 – 2021 Journal of Cardiac Failure, Associate Editor
2020 – present ACCEL, Contributing Editor
2021 – present Journal of Cardiac Failure, Editorial Board Member
2022 – present JACC Heart Failure: Associate Editor
Ad Hoc Journal Reviewer:
American Journal of Transplantation
Cardiology in Review
Cardiovascular Drugs and Therapy
Catheterization and Cardiovascular Interventions
Circulation
Circulation Heart Failure
Clinical Cardiology
Clinical Transplantation
European Journal of Heart Failure
Expert Review of Cardiovascular Therapy
JACC
JACC: Cardiovascular Imaging
JACC: Heart Failure
JAMA
JAMA Cardiology
Journal of Cardiac Failure
Journal of Heart and Lung Transplantation
The Medical Letter
Mount Sinai Journal of Medicine
Nature Clinical Practice Cardiovascular Medicine
Transplantation
Transplant Immunology
Transplant Infectious Disease
Awards and Honors:
1994 Pharmacology Research Award, Georgetown University
1995 James L. Tullis, M.D. Book Award, Deaconess Hospital
1998 Ivy DeFriez Award, Beth Israel Deaconess Medical Center
2000 Cardiology Fellowship Research Award, Columbia University
2000 Young Investigator Award, New York Cardiological Society/New York
Chapter American College of Cardiology
2005 Best Medical Grand Rounds 2004-05, Mount Sinai Medical Center
2009 Simon Dack Award, Mount Sinai Heart, for outstanding teaching and
contributions to the cardiology training program
2017 Cullman Family Award for Excellence in Physician Communication
(Top 1% nationally in CMS Patient Experience Survey)
2009-2021 Top Doctors: New York Metro Area, Castle Connolly
2021 New York Magazine: Top Doctors 2021
2021 Senior Faculty Scholar, Bucksbaum Institute for Clinical Excellence
Teaching Experience:
Precepting
1997-1998 Preceptor for second year medical students, Patient-Doctor II
Harvard Medical School
1997-1998 Medical service ward attending, Beth Israel Deaconess Medical Center
1999 Assistant preceptor for third year medical students, Columbia University
College of Physicians and Surgeons
2001-2004 Preceptor, third year medical students, Columbia University College of
Physicians and Surgeons
2002-2004 Resident’s Report, Columbia University, 3-4 sessions yearly
2004-2020 Teaching Attending, Coronary Care Unit, Mount Sinai Hospital
2004-2020 Resident’s Report, Mount Sinai Medical Center, 3-4 sessions yearly
2014-2020 MD/PhD Clinical Refresher Course, Cardiology
Mentorship
2005-2006 Donald Haas, MD. Advanced Heart Failure Cardiologist, Abington Memorial Hospital.
2006-2007 Eric Adler, MD. Medical Director, Cardiac Transplant and VAD Program,
University of California San Diego.
2007-2008 Gerin Stevens, MD. Director of Heart Failure Services, Northwell Health System, Great Neck, NY.
2008-2009 Ajith Nair, MD. Advanced heart failure cardiologist, St. Luke’s/Texas
Heart Institute, Houston, TX.
2009-2010 Natalia Hochbaum, MD. Advanced heart failure cardiologist, Beth Israel Newark Medical Center, Newark, NJ.
2010-2011 Michelle W. Bloom, MD. Director, Cardio-oncology, Advanced heart failure cardiologist, Stony Brook University Health Sciences Center.
2011-2012 Laura A. M. Murphy, MD. Advanced heart failure cardiologist, University of Toledo Medical Center.
2012-2013 Natasha Lipson-Altman, MD. Advanced heart failure attending, Colorado University, Aurora, CO.
2012-2014 Michael Chen, MD. Advanced heart failure cardiologist, Yale University, New Haven, CT.
2013-2014 Raymond Bietry, MD. Advanced heart failure cardiologist, Seton Healthcare, Austin, TX.
2014-2015 Maria Trivieri, MD. Director Pulmonary Hypertension Program, Icahn School of Medicine at Mount Sinai, New York, NY.
2015-2016 Noah Moss, MD. Advanced heart failure cardiologist, Medical Director MCS Program, Mount Sinai Hospital, New York, NY.
2016-2017 Elliot Levine, MD. Advanced heart failure cardiologist, Westchester Medical Center, Valhalla, NY.
2017-2018 Preethi Pirlamarla, MD. Advanced heart failure cardiologist, Thomas Jefferson University Hospital, Philadelphia, PA.
2017-2018 Val Rakita, MD. Advanced heart failure cardiologist, Temple University, Philadelphia, PA.
2018-2019 Aditya Parikh, MD. Advanced heart failure cardiologist, Mount Sinai Hospital, New York, NY.
2019-2020 Estefania Oliveros, MD. Advanced heart failure and pulmonary hypertension, Temple University, Philadelphia, PA.
2019-2020 Vinh (John) Chau, MD. Advanced heart failure cardiologist, Advocate Christ Hospital, Chicago, IL.
2019-2020 Kiran Mahmood, MD. Advanced heart failure cardiologist, Mount Sinai Morningside, New York, NY.
2020-2021 Haider Nazeer, MD. Advanced heart failure cardiologist, NYU Winthrop Hospital, Mineola, NY.
2020-2021 Indra Bole, MD. Advanced heart failure cardiologist, Ohio State, Columbus, OH.
PhD Thesis Advisor
2016-2017 Nana Toyoda, MD
Investigating Epidemiology and Long-Term Outcomes of Infective Endocarditis
2017-2019 Aaron Weiss, MD
Development of Risk Prediction Models Using Machine Learning for Patients Undergoing Complex Heart Valve Surgery
2017- Joseph Borrello
Auxetic time-release support device for chronic myocardial infarction
2018-2022 Rupa Iyengar, MD
The Association of Cardiovascular Diseases, Heart Failure with Preserved Ejection Fraction and Post-Traumatic Stress Disorder in a Middle-Aged Population from a Substudy of the World Trade Center First Responders
2019- Doaa Alsaleh, MD, MSCR
Long-term outcomes after multiple vessel coronary bypass grafting.
Course Directorship:
2014 Co-chair, 3rd Annual HFSA Board Review in Advanced Heart Failure &
Transplant Cardiology, Dallas, TX.
2016 Co-chair, St. Jude Medical MCS User’s meeting, Phoenix, AZ.
2016 Co-chair, 4th Annual HFSA Board Review in Advanced Heart Failure & Transplant Cardiology, Chicago, IL.
2016 Director, 1st Annual Mount Sinai Advanced Heart Disease Symposium, New York, NY.
2017 Director, 2nd Annual MS Advanced Heart Disease Symposium
New York, NY
2017 Co-director, HFSA Comprehensive Heart Failure Review and Update Course, Scottsdale, AZ.
2018 Co-director, HFSA Advanced Heart Failure & Transplant Cardiology
Board Certification Review Course, Chicago, IL.
2018 Director, 3rd Annual MS Advanced Heart Disease Symposium,
New York, NY
2019 Co-director, HFSA Comprehensive Heart Failure Review and Update Course, Tampa, FL.
2019 Director, 4th Annual MS Advanced Heart Disease Symposium, New York, NY.
2021 Co-director, 3rd Annual Courage and Innovation Symposium, Chicago, IL.
2022 Co-director, 4th Annual Courage and Innovation Symposium, Chicago, IL.
Invited Teaching Presentations – Local:
3.2001 Critical Care Grand Rounds, Columbia-Presbyterian Medical Center,
“Mechanical complications of acute myocardial infarction.”
8.2002 Medicine Lecture Series, St. Vincent’s Hospital, Bridgeport, CT “Acute Coronary Syndromes.”
5.2003 Short Hills Roundtable, Morristown Memorial Hospital, “Evaluation and management of the heart failure patient.”
11.2003 Transplant in Clinical Practice Symposium sponsored by New York Presbyterian Hospital, “Physiology of the transplanted heart.”
5.2004 Medicine Lecture Series, Cabrini Hospital, Brooklyn, NY. “Pharmacologic management of congestive heart failure.”
9.2004 Medical Grand Rounds, Elmhurst Hospital, Queens, NY “Chronic Heart Failure 2004: Update on clinical trials.”
9.2004 Medical Grand Rounds, Mount Sinai Medical Center, “Chronic Heart Failure 2004: Focus on improving outcomes.”
3.2005 General Internal Medicine Grand Rounds, Mount Sinai Medical Center, “Chronic Heart Failure 2005: focus on improving outcomes.”
3.2005 Transplant Grand Rounds, Mount Sinai Medical Center, “Clinical Cardiac Transplantation 2005.”
6.2005 New York Area Regional Conference, Adult Congenital Heart Association, “Cardiac transplantation for the treatment of adult congenital heart disease.”
9.2005 Intensive Board Review and Update in Geriatric Medicine 2005, Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, “Congestive Heart Failure.”
10.2005 Medical Grand Rounds, Cabrini Medical Center, Brooklyn, NY. “Contemporary Management of Heart Failure.”
5.2006 Medical Grand Rounds, North General Medical Center, Harlem, NY. “Contemporary Management of Heart Failure.”
6.2006 An Evidence-Based Approach to Hospital Management, Page and William Black Post-Graduate School, Mount Sinai School of Medicine, “Management of acute decompensated heart failure.”
9.2006 Medical Grand Rounds, St. Vincent’s Medical Center, Bridgeport, CT, “Diagnosis and Management of Pulmonary Hypertension.”
9.2006 Primed Institute, Clinical focus in cardiology, Secaucus, NJ “Modern therapy of heart failure.”
9.2006 Intensive Board Review and Update in Geriatric Medicine 2006, Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, “Heart failure in the elderly.”
10.2006 Cardiology Grand Rounds, Mount Sinai Medical Center, New York, NY. “Cardiac Resynchronization Therapy.”
5.2007 Medical Grand Rounds, Mount Sinai Medical Center, “Treatment of Stage D Heart Failure: Cardiac Transplantation and Destination Therapy.”
6.2007 An Evidence-Based Approach to Hospital Management, Page and William Black Post-Graduate School, Mount Sinai School of Medicine, “Management of acute decompensated heart failure.”
10.2007 Intensive Board Review and Update in Geriatric & Palliative Care Medicine, Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, “Heart failure in the elderly.”
12.2007 Medical Grand Rounds, St. John’s Hospital, Queens, New York, “Management of Stage D Heart Failure.”
2.2008 Cardiology Grand Rounds, Morristown Memorial Hospital, Morristown, NJ, “Management of Stage D Heart Failure.”
3.2008 Medical Grand Rounds, St. John’s Episcopal Hospital, Far Rockaway, New York, “Management of Stage D Heart Failure.”
3.2008 Educational dinner program, Mount Sinai Heart, New York, NY,
“Management of Stage D heart failure: VAD and transplant.”
3.2008 Cardiology Grand Rounds, Stony Brook University Medical Center, Stony Brook, NY, “Management of Stage D Heart Failure.”
4.2008 Cardiology Grand Rounds, Mount Sinai Medical Center, “Treatment of Stage D Heart Failure: Heart Transplantation and Destination Therapy.”
5.2008 HeartMate XVE Training Session, Hosted at Mount Sinai Medical Center, “Role of mechanical assist devices in treating Stage D heart failure.”
9.12.08 Second Annual Cardiac Nurse Practitioner’s Symposium, Mount Sinai Heart, “Management of advanced heart failure: transplantation and ventricular assist devices.”
9.22.08 New York Symposium on Diabetes and Heart Disease, New York Academy of Medicine, “Diabetes and heart failure.”
12.5.08 Medical Grand Rounds, Long Island Jewish Medical Center, Queens, NY “Contemporary management of advanced heart failure.”
2.17.09 Cardiothoracic Surgery Grand Rounds, Mount Sinai Medical Center, “Current approaches and controversies in cardiac transplantation.”
3.19.09 Cardiology Grand Rounds, North Shore University Hospital, Manhasset, NY. “Management of Stage D Heart Failure: Cardiac Transplantation & Ventricular Assist Devices.”
6.5.09 2nd Annual Cardiac Care Associate Symposium, New York Cardiological Society and New York State Chapter ACC, New York Athletic Club, “Destination therapy for end stage heart failure.”
12.8.09 Medicine Grand Rounds, Richmond University Medical Center, Staten Island, NY. “Management of acute decompensated heart failure.”
2.4.10 General Internal Medicine Grand Rounds, Mount Sinai Medical Center, New York, “Models and mechanisms of chronic heart failure.”
3.22.10 Cardiology Grand Rounds, UMDNJ-Robert Wood Johnson, New Brunswick, NJ, “Current approaches and controversies in advanced heart failure.”
5.27.10 Medicine Grand Rounds, Interfaith Medical Center, Brooklyn, NY, “Management of acute decompensated heart failure.”
10.8.10 Medicine Grand Rounds, Good Samaritan Hospital, West Islip, NY, “Destination therapy for end-stage heart failure.”
12.11.10 Dialysis Access: From Mapping to Maintenance, Helmsley Park Lane, New York, NY, “Congestive heart failure and dialysis access.”
2.7.11 Cardiology Grand Rounds, Mount Sinai Medical Center, New York. “Current approaches and controversies in cardiac transplantation.”
4.6.11 General Internal Medicine Grand Rounds, Mount Sinai Medical Center, New York, “Management of acute decompensated heart failure.”
4.20.11 Cardiothoracic Surgery Grand Rounds, Mount Sinai Medical Center, New York, NY. “Current approaches and controversies in cardiac transplantation.”
9.21.11 Mount Sinai Heart-Topics in Cardiology CME program, Queens, NY. “Contemporary management of chronic heart failure.”
9.22.11 Top 10 Advances in Clinical Cardiology, Mount Sinai School of Medicine, New York, NY. “Current concepts in management of decompensated heart failure.”
12.14.11 Cardiology Grand Rounds, New York Hospital Queens, Flushing, NY. “Current concepts in management of decompensated heart failure.”
6.13.12 15th Annual Complex Coronary and Vascular Cases 2012, New York, NY. “Left ventricular assist devices: emerging roles.”
9.15.12 Top 10 Advances in Clinical Cardiology, Mount Sinai School of Medicine, New York, NY. “Role of LVADs in management of refractory heart failure.”
10.22.12 Cardiology Grand Rounds, Mount Sinai Medical Center, New York, NY. “Management of asymptomatic valvular heart disease.”
6.11.13 Complex Coronary, Valvular and Vascular Cases 2013, New York, NY, “Total artificial heart: is it really a complete change of heart?”
7.25.13 Surgical Grand Rounds, Brookdale Hospital, Brooklyn, NY. “Clinical Heart Transplantation: 2013 Update.”
8.20.13 Medical Grand Rounds, Mount Sinai Medical Center, New York, NY. “Advanced cardiac care: transplantation and mechanical support devices.”
9.13.13 Controversies in Kidney Disease, Icahn School of Medicine at Mount Sinai, New York, NY. “LVAD and kidney disease.”
10.10.13 Richmond University Medical Center, Staten Island, NY. “Advanced Heart Failure 2013: Patient selection and management.”
10.23.13 Donor Management Education Symposium, New York Cardiothoracic Transplant Consortium, Buffalo, New York. “Immunology basics, allosensitization and cross-match.”
10.26.13 Annual meeting of the New York Chapter of the American College of Cardiology, New York, NY. “The New York Cardiac Center Debate: Refractory heart failure – VAD vs. Transplant.”
12.16.13 Richmond University Medical Center, Staten Island, NY, Grand Rounds, “Update on the Management of Acute Decompensated Heart Failure.”
3.5.14 Medical Grand Rounds, Lutheran Hospital, Brooklyn, NY. “Advanced heart failure update: patient selection and management.”
3.25.14 Controversies in Cardiology. AHA Fellows Society of Greater New York. Omni Berkshire Place. New York, NY. “Cardiac arrest: keeping your cool?”
6.2.14 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Left ventricular assist devices: the adolescence of a disruptive technology.”
7.1.14 Hospital Medicine Grand Rounds, Mount Sinai Hospital, New York, NY. “Update in acute heart failure: from clinical trials to quality initiatives.”
10.1.14 Cardiology Grand Rounds, St. Luke’s-Roosevelt Hospital, New York, NY. “Defining Advanced Heart Failure: anticipating prognosis and guiding therapy.”
10.18.14 New York City Mechanical Circulatory Support Symposium. Alexandria Center, New York, NY. “Management of Adverse Events.”
10.21.14 Cardiology Grand Rounds, St. Peter’s Cardiac and Vascular Center, Albany, NY. “Defining Advanced Heart Failure: anticipating prognosis and guiding therapy.”
11.11.14 Mount Sinai Beth Israel, New York, NY. “Defining Advanced Heart Failure: anticipating prognosis and guiding therapy.”
11.24.14 Mount Sinai Health System Cardiology Nurse Practitioner Symposium, New York Academy of Medicine, New York, NY. “Heart failure management redesigned.”
2.2.15 Cardiology Grand Rounds, Mount Sinai Beth Israel Hospital, New York, NY. “Contemporary advanced heart failure management: transplantation and devices.”
3.18.15 Critical Care Grand Rounds, Mount Sinai Hospital, New York, NY. “Contemporary management of mechanical circulatory support therapy.”
4.16.15 Medical Grand Rounds, Mount Sinai Hospital Queens, Astoria, NY. “Heart failure management redesigned.”
6.18.15 11th Annual Challenges in Internal Medicine, Mount Sinai Health System, New York, NY. “Heart Failure Management 2015.”
7.7.15 Hospitalist Grand Rounds, Mount Sinai Hospital, New York, NY. “Heart failure management: 2015.”
10.5.15 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Palliative care in advanced heart disease.”
10.6.15 Mount Sinai Heart – Topics in Cardiology, Queens, NY. “Neprilysin inhibitors: the next big advance in chronic heart failure.”
10.11.15 15th Annual Echo New York, New York, NY. “Role of echocardiography in diagnosis, risk stratification of heart failure patients.”
10.13.15 Cardiology Grand Rounds, Lenox Hill Hospital, New York, NY. “Update in chronic heart failure: incorporating recent advancements into clinical practice.”
10.26.15 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Update in chronic heart failure: incorporating recent advancements into clinical practice.”
12.1.15 AHA Fellows Society of Greater New York, New York, NY. “Shocking revelations: management of cardiogenic shock in the current era.”
6.1.16 Cardiology Grand Rounds, Mount Sinai St. Luke’s, New York, NY. “Heart Transplantation.”
6.15.16 12th Annual Challenges in Internal Medicine, Mount Sinai Health System, New York, NY. “Heart Failure Management 2016.”
9.29.16 Medicine Grand Rounds, Metropolitan Hospital, New York, NY. “What’s new in CHF management 2016.”
9.30.16 Grand Rounds, Visiting Nurse Service of New York, “Advanced Heart Disease: how hospice and palliative care can help.”
11.5.16 1st Annual Mount Sinai Advanced Heart Disease Symposium, New York, NY. “Chronic heart failure update: incorporating sacubitril/valsartan and ivabradine into clinical practice” and “VADs for lifelong therapy: Stage D treatment of choice.”
11.28.16 Cardiology Grand Rounds, Mount Sinai Beth Israel, “Advances in Chronic Heart Failure.”
12.5.16 Cardiology Grand Rounds, New York Presbyterian-Cornell Medical Center, “Managing Advanced Heart Failure: from molecules to machines.”
5.17.17 Mount Sinai Heart — Topics in Cardiology, Forest Hills, Queens NY. “Cardiac Amyloidosis: more common than you think.”
6.21.17 13th Annual Challenges in Internal Medicine, Mount Sinai Health System, New York, NY. “CHF Management 2017.”
8.15.17 Hospitalist Grand Rounds, Mount Sinai Hospital, New York, NY. “Advances in Inpatient Heart Failure Management: 80 is the new 40.”
9.11.17 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Advances in Heart Failure.”
10.20.17 2nd Annual Mount Sinai Advanced Heart Disease Symposium, New York, NY. “The importance of the right heart.”
10.21.17 12th Annual Mid-Atlantic Hospital Medicine Symposium, ISMMS, New York, NY, “Advances in inpatient heart failure management.”
1.17.18 New Horizons in Cardiovascular Care for the Primary Care Physician, Central Harlem, NY. Sponsored by Mount Sinai and the Association of Black Cardiologists. “Congestive Heart Failure: Paradigm shift or paradigm drift?”
3.15.18 Medicine Grand Rounds, Mount Sinai St. Luke’s, New York, NY. “Stage D Heart Failure: Defining the Phenotype and Advancing Care.”
6.20.18 14th Annual Challenges in Internal Medicine, Mount Sinai Health System, New York, NY. “CHF Management 2018.”
10.10.18 Cardiology Grand Rounds, New York Presbyterian Queens, Queens, NY. “Update in heart failure management.”
10.11.18 3rd Annual Mount Sinai Advanced Innovations in Heart Failure, New York, NY. “What have clinical trial of cardiogenic shock taught us?” & “Non-Invasive Assessment of Allograft Rejection.”
12.12.18 Hospital Medicine Grand Rounds, Mount Sinai Beth Israel, New York, NY. “Update in Acute Heart Failure: Decongestion, Transition & Remote Monitoring”
1.15.19 Medical Grand Rounds, Mount Sinai Hospital, New York, NY. “Innovation in heart failure: from molecules to machines.”
1.29.19 AHA Fellows Society of Greater New York, New York, NY. “Mitral valve regurgitation in HFrEF: when to clip and when to snip.”
2.7.19 Medical Grand Rounds, Mount Sinai Brooklyn, Brooklyn, NY. “Update in acute heart failure: decongestion, transition & remote monitoring.”
2.12.19 Medicine Grand Rounds, Mount Sinai Beth Israel, New York, NY. “Update in acute heart failure: decongestion, transition & remote monitoring.”
2.27.19 Medicine Grand Rounds, Mount Sinai Queens, Astoria, NY. “Update in acute heart failure: decongestion, transition & remote monitoring.”
3.25.19 Cardiology Grand Rounds, Mount Sinai Beth Israel, New York, NY. “Left ventricular assist devices for lifelong support.”
5.11.19 Long Island Heart State-Of-The-Art Cardiovascular Care for the Clinician, Melville, NY. “Cardiac transplantation after 50 years.”
6.17.19 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Fifty years of heart transplantation.”
6.19.19 15th Annual Challenges in Internal Medicine, Icahn School of Medicine, New York, NY. “CHF management 2019.”
9.25.19 American Heart Association Lifesaver Dinner, New York, NY. “Innovation in Heart Failure.”
10.10.19 4th Annual Mount Sinai Advanced Innovations in Heart Failure, New York, NY. “Intersection of atrial fibrillation and heart failure” & “Can we eliminate protocol biopsies: the case for molecular diagnosis of rejection.”
5.27.20 Cardiology Grand Rounds, Mount Sinai Hospital, New York, NY. “Device therapy for Heart Failure.”
9.24.20 Medicine Grand Rounds, University of Chicago, Chicago, IL. “Device therapy for heart failure.”
3.6.2021 3rd Annual Courage and Innovation Symposium, University of Chicago, Chicago, IL. “The Past, Present, and Future of Transplant Medicine.”
5.20.21 Nursing Grand Rounds, University of Chicago, Chicago, IL. “Heart Failure Disease Management.”
6.23.21 Grand Rounds, Ingalls Practice Group, Ingalls Hospital, Harvey, IL. “Heart Failure Management.”
10.16.21 Illinois Chapter ACC Annual Symposium, “Heart Failure – New drugs and new indications for HFrEF, HFmrEF and HFpEF.”
11.18.21 Chicagoland PASC Rounds, “Myocardial sequelae from SARS-CoV-2 infection.”
1.11.22 Cardiology Grand Rounds, NorthShore Hospital, Evanston, IL. “Current Approaches in Pulmonary Hypertension Management.”
2.26.22 4th Annual Courage and Innovation Symposium, University of Chicago, Chicago, IL. “Making Progress with HFpEF: New Drugs, Devices and Procedures.”
3.23.22 Anesthesia Grand Rounds, University of Chicago, Chicago, IL. “Update in heart failure management.”
Invited Teaching Presentations – National:
10.2006 Cardiac Transplant Conference, Tufts New England Medical Center, Boston, MA. “Novel Immunosuppressive Therapy.”
5.2007 Cardiac Transplant Conference, Yale University Medical Center, New Haven, CT. “Novel Immunosuppressive Therapy.”
12.2007 40th Annual New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Surgical remodeling: coming back for specific entities? LV failure and mitral valve regurgitation.”
1.2008 Medical Grand Rounds, Lankenau Hospital, Wynnewood, PA, “Acute Decompensated Heart Failure.”
10.13.08 TCT 2008, Washington, DC, “Implications of cardiac remodeling in heart failure progression.”
12.10.11 44th Annual New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Destination LVADs: A rapidly evolving alternative to heart transplantation.”
3.25.12 American College of Cardiology (ACC.12), Chicago, IL. “Calcineurin-free immunosuppression after transplantation: why and which patients?”
5.10.12 Cardiovascular Grand Rounds, St. Luke’s Mid America Heart Institute, Kansas City, MO. “Current approaches and controversies in mechanical circulatory support and transplantation.”
6.9.12 West Coast Cardiovascular Forum, American College of Cardiology Foundation, San Francisco, CA. “State-of-the-art management of systolic and diastolic heart failure: BNP vs. standard medical symptom-guided therapy”; “Cardiac resynchronization therapy for systolic heart failure and prevention of events”; and “Destination LVADs: a rapidly-evolving alternative to heart transplantation.”
9.9.12 16th Annual Scientific Meeting HFSA, Seattle, WA. “What do you tell patients and families considering VAD therapy? Setting expectations: education or sales?”
9.30.12 HFSA Board Review Course: Advanced Heart Failure and Transplant Cardiology, Minneapolis, MN. “Immunology: basics, PRA, sensitization and crossmatch” and “Heart Transplantation: rejection and drugs.”
12.8.12 45th Annual New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Destination LVADs: A rapidly evolving alternative to heart transplantation.”
3.16.13 Destination. Life. Thoratec User’s Meeting, Orlando, Fl. “Strategies for the INTERMACS 1 patient.”
5.2.13 49th Annual Robert M. Jeresaty, M.D. Cardiovascular Symposium, West
Hartford, CT. “Left ventricular assist devices: a rapidly emerging alternative to heart transplantation.”
9.24-5.13 17th Annual Scientific Meeting HFSA, Orlando, FL. “Patient selection, management and troubleshooting durable ventricular assist devices: Device selection” and “Risk stratification for advanced heart failure therapies: how much pulmonary hypertension is too much?”
11.1-3.13 2013 HFSA Comprehensive Review & Update, The Practical Management of Heart Failure: From Prevention to Advanced Disease, Chicago, IL. “Hypertrophic and infiltrative cardiomyopathies”; “Cardiac transplantation: patient selection and management”; and “Mechanical circulatory support: patient selection.”
3.29-31.14 American College of Cardiology (ACC.14), Washington, DC. “Updates on new pharmacotherapeutic and device approaches in acute decompensated heart failure” and “Short and long term outcomes of medical management, heart transplant or LVAD.”
4.9.14 XDx/Diaxonhit AlloMap symposium – ISHLT Congress, San Diego, CA. “Heart transplant surveillance best practices: evidence and future.”
5.3.14 Destination. Life. Thoratec User’s Meeting, Salt Lake City, UT. “To VAD or not to VAD?”
5.17.14 29th Annual Scientific Meeting, American Society of Hypertension, New York, NY. “New vasoactive drug development: serelaxin.”
9.14-17.14 18th Annual Scientific Meeting, Heart Failure Society of America, Las Vegas, NV. Moderator, “Contemporary issues in pulmonary hypertension.” Speaker, “Patient selection, management and troubleshooting durable ventricular assist devices: Perioperative management”, “Are we there yet? How to determine when you have reached the limits of medical therapy” and “Prediction of right heart failure: clinical models.”
9.27.14 HFSA Board Review in Advanced Heart Failure and Transplant Cardiology, Dallas, TX. “Heart transplantation: immunology basics, allosensitization and cross-match” and “Heart transplantation: rejection and its treatment.”
12.9.14 Cardiology Grand Rounds, University of South Florida/Tampa General Hospital, Tampa, FL. “Defining Advanced Heart Failure: anticipating prognosis and guiding therapy.”
4.24.15 AATS Mitral Conclave 2015, New York, NY. “Guideline directed medical therapy in severe ischemic mitral regurgitation: Can implantable pulmonary artery sensors help guide therapy?”
5.15.15 Medicine Grand Rounds, Lankenau Medical Center, Wynnewood, PA. “Defining advanced heart failure.”
6.8.15 Improving Palliative Care for Patients with Heart Failure and Family Caregivers: creating an agenda for research and clinical priorities, Birmingham, AL. “The Medicare heart failure bundle and value-based purchasing.”
9.28.15 19th Annual Scientific Meeting, Heart Failure Society of America, National Harbor, Maryland. Moderator, “Emergency management of VAD patients”, Speaker, “Navigating patient conversations: tough choices with advanced heart failure therapies”
10.25.15 2015 HFSA Comprehensive Review & Update, Tampa, FL. “Acute and chronic MCS”, and “Cardiac transplantation: patient selection and pre/post-transplant management.”
11.9.15 American Heart Association Scientific Sessions, Orlando, FL. ABIM Learning Session—Advanced heart failure and transplant cardiology, 2015 update.
12.12.15 48th Annual New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Destination LVADs advances 2014-2015: a rapidly evolving alternative to heart transplantation.”
2.26.16 Cutting Edge of Transplantation, American Society of Transplantation, Phoenix, AZ. “The value of thyroid hormone, corticosteroids, hypothermia and other means to maintain/improve donor heart function.”
4.2-4.16 ACC.16, Chicago, IL. “The research says…Optimization of pharmacological therapies old and new”, “Recent advances in LVADs: an evolving alternative to heart transplantation”, and “Timing and selection of patients for heart transplant.”
4.27.16 9th Annual ICCAC Meeting, Washington, DC. “EMS Partnering with MCS in the Community: What We Have Accomplished and Where We Are Going.”
5.7.16 13th Annual Ponte Vedra Beach Cardiovascular Symposium, Jacksonville, FL. “Left ventricular assist devices for lifelong therapy.”
5.21.16 Course Director, St. Jude Thoratec User’s meeting, Pheonix, AZ. “State of the art: continuous flow LVADs as a disruptive technology.”
8.20.16 4th Annual Board Review Course in Advanced Heart Failure & Transplant Cardiology, Chicago, IL. “Immunology: the basics, PRA, sensitization and crossmatch” and “Rejection: cellular and antibody mediated.”
2.1.17 SCMR/ISMRM Co-provided workshop, Washington, DC, “Characterizing the spectrum of heart failure.”
2.2-3.17 AST Cutting Edge of Organ Transplantation, Phoenix, AZ. “Treatment of detected antibodies” and “Case Discussion: pre-transplant treatment of the sensitized patient.”
3.16-19.17 ACC.17, Washington, DC. “Panelist: The Great K Debate Continues” and “Treatment strategies for end-stage HF: Heart transplant is always the best option.”
4.29.17 Consensus Conference: Frailty in Thoracic Transplantation, Chicago, IL. “Developing a Frailty Score for Thoracic Transplant Candidates.”
5.1.17 American Transplant Congress. Chicago, IL. “Significant CAD: When is it critical? When to revascularize?”
9.16-19.17 21st Annual Scientific Meeting, Heart Failure Society of America, Dallas, TX. “Role of PA Monitoring and Reducing Heart Failure Hospitalizations” and “Tweeting the Experts: A Free Forum for the Hardest Questions.”
10.12-15.17 HFSA Heart Failure Review Course & Update, Scottsdale, AZ. “Hemodynamics of cardiogenic shock & devices”, “Advanced hemodynamic modeling”, and “Defining advanced heart failure.”
10.27.17 Practicum in Mechanical Circulatory Support: An Expert Review and Interactive Simulations, Cedars-Sinai Medical Center, Los Angeles, CA. “Making Informed Decisions (INTERMACS Profiles and Special Populations).”
3.8-9.18 AATS Mechanical Circulatory Support Symposium, Houston, TX. “Predicting outcomes in LVAD recipients”, “Medical management of device thrombosis” and “Class III patients should undergo LVAD implantation: con.”
3.12.18 ACC.18, Orlando, FL. “Heart Failure and Transplant Section: digital platform highlights.”
6.2.18 American Transplant Congress, Seattle, WA. “Evaluation and Management of Ischemic Heart Disease Prior to Liver Transplantation: From Regulatory to Reality: Critical Coronary Artery Stenosis in a 45-year-old with a MELD of 40.”
8.17-19.18 2018 Advanced Heart Failure & Transplant Cardiology Board Certification Review Course, Chicago, IL. “Immunology: the basics, PRA, sensitization and crossmatch” and “Rejection: cellular and antibody mediated.”
9.14.18 Cardiology Grand Rounds, University of Chicago, Chicago, IL. “Mitral Regurgitation: Management across the spectrum of heart failure.”
9.15.18 Satellite Symposium at HFSA 2018, Nashville, TN. “ReDS Point of Care:
Rapid Follow-Up (RFU).”
9.15-16.18 22nd Annual Scientific Meeting, Heart Failure Society of America, Nashville, TN. “The old and the new: selecting between approved mechanical circulatory support devices” & “One transplant for life: overcoming CAV, ESRD and cancer.”
10.18.18 Allan J. Goody Visiting Professorship and Lecture, Georgetown University Medical Center, Washington, DC. “Left Ventricular Assist Devices for lifelong support.”
1.28.19 Cardiology Grand Rounds, Emory University, Atlanta, GA. “Innovation in advanced heart failure: from molecules to machines.”
2.1.19 Cardiology Grand Rounds, University of California San Diego, La Jolla, CA. “Mitral regurgitation: management across the spectrum of heart failure.”
2.20.19 Cardiology Grand Rounds, Barnes-Jewish Medical Center, Washington University, St. Louis, MO. “Innovation in advanced heart failure: from molecules to machines.”
3.16.19 ACC.19, New Orleans, LA. “Build the bridge over troubled waters: digital devices in heart failure.”
4.3.19 ISHLT Annual Meeting, Orlando, FL. “Atrial fibrillation and flutter in LVAD patients: incidence, significance and management.”
4.12.19 ARCH 2019, St. Louis, MO. “What is guideline-directed medical therapy in patients with functional mitral regurgitation?”
5.3.19 AATS Mitral Conclave, New York, NY. Guideline-directed medical therapy for patients with secondary MR.”
9.16.19 Satellite Symposium at HFSA 2019, Philadelphia, PA. “ReDS Point of Care:
The Mount Sinai Experience.”
9.16.19 23rd Annual Scientific Meeting, Heart Failure Society of America, Philadelphia, PA. “Prevention is better than a cure: treating early in heart failure – is there a precedent?”
10.4.19 6th Annual Yale Comprehensive Heart Failure Symposium, New Haven, CT. “An update in using novel diagnostics in cardiac transplantation.”
10.18.19 2019 Heart Failure User’s Meeting, Phoenix, AZ. “New controversies in patient selection.”
10.25.19 2019 HFSA Comprehensive Heart Failure Review Course and Update, Tampa, FL. “Impact of atrial fibrillation on heart failure” & “Defining advanced heart failure.”
11.1.19 ACC Heart House, How to Become a Cardiovascular Investigator, Washington, DC. “Careers in cardiac failure and transplant.”
3.25.20 Virtual ACC.20. “Transplantation vs LVAD: Who? How? When?”
7.24.20 HFSA 2020 Advanced Heart Failure & Transplant Cardiology Board Certification Review Course (Virtual). “Immunology: the basics, PRA, sensitization and crossmatch” and “Rejection: cellular and antibody mediated.”
9.24-25.20 AST Fellows Symposium on Transplantation (Virtual), Breakout Sessions “Immunosuppression mechanisms, novel agents and complications” and “Management of post-transplant complications.”
10.4.20 24th Annual Scientific Meeting, Heart Failure Society of America (Virtual). “Recovering ejection fraction after viral myocarditis: who, why and what are we going to learn from COVID-19?”
11.20.20 Transplantation Grand Rounds, Hartford Hospital, Hartford, CT. “Non-invasive rejection surveillance.”
12.13.20 New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Assist Devices in Cardiac Decompensation – The 2 Challenges.”
4.17.21 18th Annual North Florida Cardiovascular Symposium, Jacksonville, FL. “COVID-19 and the Heart.”
5.16.21 ACC.21 (Virtual). “Current and future monitoring devices: what information can we possibly capture.”
7.16.21 HFSA 2021 Advanced Heart Failure & Transplant Cardiology Board Certification Review Course (Virtual). “Immunology: the basics, PRA, sensitization and crossmatch” and “Rejection: cellular and antibody mediated.”
7.20.21 TVT 2021, Miami, FL. “Should Patient Selection for TEER in FMR Be Limited to the COAPT Criteria?”
9.12.21 HFSA Annual Scientific Meeting, Denver, CO. “Allosensitization, desensitization, and AMR: strategies to overcome a high PRA” and “Clinical conundrums – multidisciplinary case discussion.”
10.21.21 AST Fellows Symposium on Transplantation (Virtual), Breakout Sessions “Antibody Mediated Rejection – diagnosis and treatment” and “Cardiac Allograft Vasculopathy.”
10.29.21 Brigham and Women’s Hospital Center for Advanced Heart Disease Grand Rounds. “Noninvasive Monitoring of Heart Transplant Rejection.”
11.4.21 TCT 2021, Miami, FL. “The Role of Heart Failure Optimization Pre- and Post-Tricuspid Valve Procedure.”
12.12.21 New York Cardiovascular Symposium, American College of Cardiology, New York, NY. “Assist Devices in Cardiac Decompensation – Two Challenges.”
12.17.21 Cardiology Grand Rounds, Dartmouth Hitchcock Medical Center, Lebanon, NH. “Contemporary Management of Cardiogenic Shock.”
1.27.22 AST Consensus Conference on the Evolving Use of Biomarkers in Renal and Cardiac Transplantation (Virtual). “Are Any Biomarker Diagnostics Ready for Prime Time Now? Heart.”
2.2.22 Technology and Heart Failure Therapeutics (THT), New York, NY. “Use of Transthoracic Radar Monitoring for Assessing Volume Status.”
4.3.22 ACC.22, Washington, DC. “Assist Devices in Cardiac Decompensation: Two Challenges.”
4.7.22 Cutting Edge of Transplantation (Virtual). AST Transplant Visionaries Challenge.
4.28.22 Transmedics National OCS Program, Boston, MA. “Overview of the US OCS Heart Perfusion Registry (OHP) – Real world clinical evidence in the post market setting.”
4.29-30.22 Apollo National Investigator Meeting, New York, NY. “Heart Failure Perspective: navigating mitral valve treatment options.”
5.4.22 58TH Annual Jeresaty Cardiovascular Symposium, Hartford, CT (Virtual). “Device Therapy for Heart Failure.”
6.6.22 ATC 2022, Boston, MA. “Shifting the Paradigm from Observation to Intervention: The Future of HeartCare.”
6.7.22 ATC 2022, Boston, MA. “LVAD Will Be Only a Destination Therapy Going Forward and We Are Committing Patients to LVAD for Life.”
6.9.22 TVT 2022, Chicago, IL. “The “New” Heart Failure GDMT Guidelines “FOR DUMMIES”: What Every Structural Interventionalist Needs to Know.”
6.9.22 TVT 2022, Chicago, IL. “What Are the Indicators That GDMT Is Maximized in the Symptomatic Patient?”
Invited Teaching Presentations – International:
1.15.10 2nd Transplant Symposium Freiberg, University Medical Center Freiberg,
Germany, “Post-transplant renal dysfunction is (not) mostly an effect of
direct CNI toxicity.”
4.17.12 ISHLT Academy: Core Competency – Mechanical Circulatory Support,
Prague, Czech Republic. “Trouble shooting: hemolysis & bleeding.”
4.19.12 ISHLT annual meeting, Prague, Czech Republic. “Tough situations in
cardiac transplantation: bring in the experts.”
1.19.13 3rd Annual Cardiovascular Symposium India, ACC International Distance Educational Programme, Mumbai, India. “Systolic dysfunction-clinical and hemodynamic guide for management: new medical and interventional therapeutic challenges” and “Destination LVADs: A rapidly evolving alternative to heart transplantation.”
4.23.13 ISHLT Academy: Core Competencies in Mechanical Circulatory Support,
Montreal, Canada. “Long-term management/case studies.”
10.18.13 Argentine Society of Cardiology / Inter-American Society of Cardiology Meeting, Buenos Aires, Argentina. “Understanding the burden of acute heart failure on patients and the healthcare system.”
2.2.14 4th Annual ACCF Cardiovascular Symposium, New Dehli, India. “Heart failure device therapy: ICDs, CRT, autonomic modulation, systolic dysfunction, mitral regurgitation” and “Destination LVADs: Advances 2013-14, a rapidly evolving alternative to heart transplantation.”
9.9.15 The Best of ACC 2015, Kochi, India. “Update in chronic heart failure: incorporating recent advancements into clinical practice” and “Optimizing acute heart failure care: a review of the fundamentals.”
9.12.15 The Best of ACC 2015, Mumbai, India.
9.16.15 The Best of ACC 2015, Kathmandu, Nepal.
9.18.15 The Best of ACC 2015, Dhaka, Bangladesh.
7.3.16 Need Conclave and Sarathi Scientific Forum, Prague, Czech Republic. “Defining and assessing Stage D heart failure”, “Optimizing acute heart failure care: a review of the fundamentals”, and “Cardiogenic shock and advanced heart failure therapies: role of mechanical circulatory support.”
12.3-5.17 ICI 2017 Meeting, Tel Aviv, Israel. “Heart failure management in the digital age” and “Heart failure monitoring.”
4.11.18 ISHLT Annual Meeting, Nice, France. “Patterns of Gene Expression in High GEP Score Samples Correlated with Clinical Factors in the Outcomes AlloMap Registry.”
5.25.18 2° Simposio Nacional: Donacion y Transplante de Organos y Tejidos, Bogota, Colombia, “Heart transplantation: past, present and future”, “Management of the sensitized patient.”
10.28.18 3rd Eternal Heart Conclave, Jaipur, India. “Novel therapies to treat heart failure” & “The continuum of heart failure care – dawn to dusk: latest advances in LVAD technology.”
12.4.18 ICI 2018 Meeting, Tel Aviv, Israel. “New and emerging device therapies for heart failure” & “Innovations in MCS: latest advances in LVAD technology.”
12.10.19 ICI 2019, Tel Aviv, Israel. “Management of End Stage Heart Failure – LVAD, BiVAD and Heart Transplant” & “Heart Failure Management with ReDS Point-of-care Technology.”
12.6.20 ICI 2020 (Virtual), Israel. “Novel Device Therapy for Cardiorenal Syndrome” & “Remote HF Monitoring: Becoming Standard of Care.”
12.7.21 ICI 2021 (Hybrid), Tel Aviv, Israel. “Remote patient monitoring with a non-invasive multimodal sensor: The ADI CardioPulmonary Management (CPM) System.”
4.29.22 China Valve, Hangzhou, China (Virtual). “Optimal heart failure management in patients with FMR before and after TEER or TMVR.”
6.11.22 University of Chicago International Conference on Organ Transplant, Abu Dhabi, UAE. “Defining advanced heart failure and timing of referral.”
Controversies in Cardiology, Mount Sinai Medical Center, New York, NY
Moderator:
2.2005 Medical versus surgical treatment of congestive heart failure.
Guest: Lynne Warner Stevenson, MD.
5.2005 Diastolic Heart Failure.
Guest: G. William Dec, MD.
12.2005 Post Myocardial Infarction Remodeling.
Guest: Marc Pfeffer, MD.
5.2006 Management of acute decompensated heart failure.
Guest: Clyde Yancy, MD.
5.2007 Myocarditis: New insights into an old disease.
Guest: Kenneth Baughman, MD.
11.22.10 Appropriate use of mechanical support devices in chronic heart failure.
Guest: Paul Hauptman, MD.
1.24.11 Expanding the treatment paradigm: advanced therapies for mild heart failure. Guest: Mariell Jessup, MD.
10.17.11 Contemporary management of chronic heart failure: biomarkers and disease management programs.
Guest: Marvin Konstam, MD.
12.12.11 Diastolic heart failure.
Guest: Milton Packer, MD.
11.11.13 Contemporary use of beta-blockers in heart failure.
Guest: Andrew R. Marks, MD.
1.25.16 LVAD therapy for less advanced heart failure patients.
Guest: Keith Aaronson, MD.
11.19.18 Approach and timing of advanced therapy in end stage heart failure
Guest: Jon Kobashigawa, MD.
5.20.19 LVADs for myocardial recovery
Guest: Mandeep R. Mehra, MD.
Panelist:
9.2004 Use of implantable cardiac defibrillators in patients with systolic dysfunction. Guest: Alan Kadish, MD.
4.2006 Cardiac resynchronization therapy.
Guest: Hasan Garan, MD.
6.2007 Diastolic heart failure: Insights into mechanism and management.
Guest: Anthony DeMaria, MD.
10.20.08 Treatment of Stage D Heart Failure: Are VADs the answer?
Guest: Leslie Miller, MD.
10.27.09 When to start treatment for pulmonary arterial hypertension.
Guest: Robyn Barst, MD.
1.23.12 Risk stratification for sudden death.
Guest: David Wilbur, MD
2.27.12 Cell therapy for chronic ischemic heart disease.
Guest: Joshua M. Hare, MD
6.17.13 Treatment for ischemic and non-ischemic ventricular tachycardia.
Guest: Mark Josephson, MD
12.16.13 Sudden death in coronary artery disease: are defibrillators enough?
Guest: William G. Stevenson, MD
2.10.14 Controversies in Device therapy
Guest: Andrew E. Epstein, MD
6.16.14 The role of biomarkers as surrogate endpoints in heart failure.
Guest: Christopher O’Connor, MD
9.21.15 Heart Failure with Preserved Ejection Fraction
Guest: Allan Klein, MD
4.18.16 Rate, rhythm & heart Failure.
Guest: Gregg Fonarow, MD
5.23.16 Restrictive Cardiomyopathies: new approaches to diagnosis and treatment
Guest: James D. Thomas, MD
11.21.16 Personalized Heart Failure: diagnosis and treatment.
Guest: Joseph Hill, MD, PhD
3.20.17 Arrhythmia device therapy in heart failure
Guest: Michael R. Gold, MD
4.24.17 LV Non Compaction: a distinct cardiomyopathy?
Guest: Jennifer L. Hall, PhD
10.23.17 Ventricular Irritability: from VPB’s to Tachycardia
Guest: Bruce B. Lerman, MD
12.18.17 Biomarkers in heart failure
Guest: James L. Januzzi Jr, MD
3.25.19 Atrial fibrillation
Guest: Douglas Packer, MD
11.25.19 Mitral Regurgitation: Evidence-Based Management 2019
Guest: Robert O. Bonow, MD
2.24.20 Atrial Fibrillation, where to after CABANA?
Guest: Francis E. Marchlinski, MD
Research Experience:
Ongoing Research
The Aortix CRS Pilot Study 3/31/2022-present
Procyrion Inc.
An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome
Role: Site PI
REBALANCE-HF 2/17/2022-present
Axon Therapies, Inc.
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF: Feasibility Study: Randomized Controlled Feasibility Trial- Rebalance HF Study
Role: Site PI
ARIES HM3 7/20/2021-present
Abbott, Inc.
Antiplatelet Removal and HemocompatIbility EventS with the HeartMate 3 Pump (ARIES HM3)
Role: Site PI
Pending Research Support
1R41HL139163-01A1 GRANT12474517 (Pinney) 5/1/18-4/30/19 0.6 Calendar
NIH/NHLBI $125,872
Development of a Predictive Digital Health Technology for Heart Failure Outpatients to Improve Clinical Interventions and Statistical Prediction of Hospital Readmission
Completed Research Support
Surveillance HeartCare Outcomes Registry (SHORE) 12/1/2019-6/30/2020
CareDx
Prospective, multi-center, observational, registry of heart transplant patients receiving HeartCare surveillance testing
Role: Site PI
CRS Registry 6/1/2019-6/30/2020
Sponsor: Procyrion, Inc
Cardiorenal syndrome registry of hospitalized heart failure patients
Role: Site PI
RTB-004 12/18/18-6/30/2020
Sponsor: NIAID
ALL-IN: Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab.
Role: Site PI
PERFECT (Pinney) 5/17/18-6/30/2020
United Therapeutics Inc
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Role: Site PI
EMPA-TROPISM 2017-6/30/2020
Investigation of the effects of empagliflozin versus placebo in HFrEF patients.
Sponsor: Juan Badimon, PhD (ATRU) and Boehringer Ingelheim
Role: Site Co-PI
REDUCE – LAP
Source: Corvia Medical 5/10/2016-6/30/2020
A study to evaluate the Corvia Medical, Inc. IASD® System II (inter-atrial shunt device) to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.
Role: Site PI
SOUTHPAW (Pinney) 12/1/17-12/1/19 0.6 Calendar
United Therapeutics
Double blind, placebo controlled trial evaluating the safety and efficacy of oral treprostinil (Orenitram) in subjects with PH and HFpEF.
Role: Site PI
EMPEROR-HF (Pinney) 5/1/18- 9/30/19 0.6 Calendar
Boehringer Ingelheim
A phase III randomised, double-blind trial to evaluate efficacy and safety of
once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart
Failure with reduced Ejection Fraction (HFrEF).
Role: Site PI
PIONEER HF (Pinney) 10/1/16-11/30/18 1.2 Calendar
Novartis
A multicenter, randomized, double-blind, double dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril and valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability of in-hospital initiation of LCZ696 compared to enalapril in HFrEF patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF).
Role: Site PI
OAR Registry and D-OAR Sub-study 2/23/16-12/1/18 0.6 Calendar
CareDx
Utility of Donor-Derived Cell-free DNA in Association with Gene-Expression Profiling (AlloMap) in Heart Transplant Recipient (D-OAR).
Role: Site PI
Source: Thoratec/St. Jude Medical 8/1/2015-11/1/2018
MOMENTUM3: Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol
Role: Site Co-investigator
National co-chair, medical management subcommittee
SMILE (Pinney) 12/18/15-11/30/18 1.8 Calendar
Sensible Medical Innovations, Ltd
Sensible Medical Innovations Lung Fluid Status Monitor Allows Reducing Readmission Rate of Heart Failure Patients – A Randomized Controlled Study
Role: Site PI
Source: Abbott, Inc. 2014 – 9/2018
COAPT: use of MitraClip in functional mitral regurgitation.
Role: Site co-investigator
5R21AG046703-02 09/1/2014 – 8/31/17
Source: NIH Exploratory/Developmental Research Grant Program (Parent R21)
Can Ventricular Assist Devices Reverse the Frailty Phenotype? Multi-center, prospective cohort study of older adult patients receiving VADs for advanced HF at centers in the Greater New York Geriatric Cardiology Consortium (GNYGCC) to evaluate if the frailty phenotype is reversible.
Role: Site PI
Source: NHLBI 12/15/2015-1/1/2018
REVIVAL (REVIVE IT Registry): Registry Evaluation of Vital Information for VADs in Ambulatory Life.
Role: Site Co-investigator
Source: Cardiokinetix 2013 – 2017
PARACHUTE IV: Percutaneous ventricular restoration in chronic heart failure due to ischemic disease.
Role: Site co-investigator
Source: NIH/NHLBI 04/01/12 – 03/31/17
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure
Phase1, Open-Labeled, Dose-Escalation Trial of BNP111.CMV.I1c by Intra-Coronary Infusion in patients with heart failure followed by a Phase 2, Randomized, Double-Blinded, Placebo-Controlled Dose Escalation Trial of Intra-Coronary Infusion of BNP111.sc-CMV.I1c in patients with heart failure.
Role: Site co-investigator
Source: Thoratec, Inc. 2012 – 2014
Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients (ROADMAP).
Role: Site PI
Source: SynCardia 2012 – 2014
SynCardia temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study. Role: Co-investigator
Source: NIAID & NHLBI. 2012 – 2013
CTOT-13: Individualizing Therapy for Kidney and Heart Transplant Recipients.
Evaluation of the efficacy of desensitization therapy, which includes VELCADE ® (bortezomib) and plasmapheresis, on select sensitized patients awaiting heart transplantation.
Role: Site PI
5R01HL102084-05 (Awarded to Nathaniel Goldstein) 2/7/2011-1/31/2016
Source: NIH
WISDOM. An intervention to improve ICD deactivation conversations.
Role: Site PI
Source: NIAID & NHLBI. 2011 – 2015
Clinical Trials in Organ Transplantation (CTOT-11). Prevention of cardiac allograft vasculopathy using rituximab (Rituxan) in cardiac transplantation.
Role: Site PI
Source: NHLBI, NINDS, and CIHR 2009 – 2012
LVAD Therapy: exploring the effect of intramyocardial injection of mesenchymal precursor cells on myocardial function.
Role: Site PI
Source: Terumo Heart, Inc. 2009 – 2011
Evaluation of the safety and effectiveness of the DuraHeart left ventricular
assist system in patients awaiting transplantation.
Role: Site co-investigaor.
Source: Celladon, Inc. 2008 – 2011
Phase II evaluation of calcium up-regulation by percutaneous administration of gene therapy in cardiac disease (CUPID).
Role: Site co-investigator
Source: NIAID & NHLBI 2007 – 2012
Clinical Trials in Organ Transplantation (CTOT-05). Observational study of alloimmunity in cardiac transplant recipients.
Role: Site PI
Source: Ventracor Inc. 2007 – 2009
VentrAssist Pivotal Bridge to Transplant trial.
Role: Site co-investigator.
Source: Novartis, Inc. 2006 – 2010
RAD001A2310. A 24-month, multi-center, randomized, open label non inferiority study of efficacy and safety comparing two exposures of concentration-controlled Certican with reduced Neoral versus 3.0 g MMF with standard dose Neoral in de novo heart transplant recipients.
Role: Site PI
Source: Scios, Inc. 2006 – 2007
Transplant-eligible patient management for congestive heart failure with continuous infusion of nesiritide or placebo (TMAC).
Role: Local PI.
Source: Jarvik Heart Inc. 2005 – 2010
Jarvik 2000 Pivotal Bridge to Transplant trial.
Role: Site co-investigator.
Source: Fujisawa, Inc. 2005 – 2007
Tacrolimus In Combination, Tacrolimus Alone Compared (TICTAC): a multi-center, double-blind, randomized comparison of TAC/MMF to TAC monotherapy in steroid-free cardiac transplant recipients.
Role: Site PI.
Source: World Heart, Inc 2005 – 2006
Randomized evaluation of the Novacor LVAS in a non-Transplant population study (RELIANT).
Role: Site PI.
Source: Otsuka Maryland Research Institute 2005 – 2006
Effect of tolvaptan on hemodynamic parameters in subjects with heart failure (ECLIPSE).
Role: Site PI.
Source: Fujisawa, Inc. 2004 – 2006
Intravascular ultrasound to assess coronary response to immune-suppression.
Role: Site co-investigator.
Source: NHLBI 1999 – 2001
Magnesium in coronary arteries (MAGIC): a multi-center, double-blind, placebo-controlled study of the effect of magnesium administration in patients with acute myocardial infarction. Local PI: LeRoy Rabbani, Columbia University.
Role: Study co-ordinator.
Clinical Research Steering Committees
2019- CareDx: SHORE observational registry
Surveillance HeartCare Outcomes Registry (SHORE)
2019- Procyrion: CRS registry
An Evaluation of the Safety and Performance of the Aortix System
for Intra-Aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome
2019- Vascular Dynamics: A Feasibility Study Exploring the Effect of the MobiusHD® in Patients with Heart Failure
2020- Analog Devices: Observational Clinical Data Collection Study using CardioPulmonary Management System in Patients with Chronic Heart Failure
2021- APOLLO Executive Steering Committee. Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation
2021- MOSAIC: Molecular Outcome Surveillance using AlloSure and AlloMap guided Immunomodulation in Cardiac transplant
2021- REVERSE-HF: Ultrafiltration versus IV Diuretics in Worsening Heart Failure
2022- DRAGONFLY-FMR: Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation
Patient Management Eligibility Committees:
2019 – APOLLO Pivotal Trial (Medtronic, Inc.)
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation
2020 – TRILUMINATE Pivotal Trial (Abbott, Inc.)
Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation
2020 – APOLLO EFS (Medtronic, Inc.)
Early feasibility study of the Intrepid TMVR transseptal system
2020- Intrepid Tricuspid EFS (Medtronic, Inc.)
2021 – CORCINCH-HF (Ancora, Inc)
Randomized Clinical Evaluation of the AccuCinch® Ventricular
Restoration System in Patients who Present with Symptomatic Heart
Failure with Reduced Ejection Fraction (HFrEF)
2022- DRAGONFLY TEER (Valgen Medtech)
Data Safety & Monitoring Board
2019 – SoniVie, Inc. TROPHY II: Treatment of Pulmonary Hypertension
2019 – NIH K23 HL 145140: Hemolysis and platelet activation during continuous flow mechanical circulatory support. (PI = Omar Saeed, MD)
2020 -2021 Axon therapies: First in human study of endovascular greater splanchnic nerve ablation for heart failure with preserved ejection fraction (IPA).
Clinical Event Adjudication Committees
2005- 2008 Ventracor VentrAssist Device feasibility trial.
2009- 2016 Cardiothoracic surgical trials network (CTSN), NHLBI
2018- 2020 Expanded clinical study of Tendyne Mitral Valve System
2019- BBA & Cardiovalve/Ahead
2019- Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF)
2019- Edwards Lifesciences, Triband Study
2019- Edwards Lifesciences, Clasp TR EFS
2019- Edwards Lifesciences, Clasp II TR EFS
2019- SoniVie: TROPHY II.
2020- TransMedics OCS Heart System/DCD Trial
Bibliography
Original Reports:
- Pinney SP, Koller BS, Franz MR, Woosley RL. Terfenadine increases the QT interval in isolated guinea pig heart. J Cardiovasc Pharmacol 1995; 25: 30-34.
- Pinney SP, Daly PA. Parathyroid Cyst: an uncommon cause of a palpable neck mass and hypercalcemia. West J Med 1999; 170:118-120.
- Pinney SP, Wasserman HS. Anterior myocardial infarction, acute aortic dissection and anomalous coronary artery. J Interven Cardiol 2002; 15:293-296.
- Mancini DM, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108:48-53.
- Pinney SP, Chen HJ, Liang D, Wang X, Schwartz A, Rabbani LE. Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury. J Cardiovasc Pharmacol 2003; 42:469-476.
- Lamour JM, Hsu DT, Quaegebeur JM, Pinney SP, Mital SR, Mosca RS, Chen JM, Addonizio LJ. Heart transplantation to a physiologic single lung in patients with congenital heart disease. J Heart Lung Transplant 2004; 23:948-953.
- Chen JM, Davies RR, Mital SR, Mercando ML, Addonizio LJ, Pinney SP, Hsu DT, Lamour JM, Mosca RS, Quaegebeur JM. Trends and outcomes in transplantation for complex congenital heart disease 1984-2004. Ann Thorac Surg 2004; 78:1352-1361.
- Pinney SP, Cheema FH, Hammond K, Chen JM, Edwards NM, Mancini D. Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant 2005; 24:34-37.
- Woollett IF, Pinney S, Magnano AR. Balloon dilatation of coronary sinus spasm during placement of a biventricular pacing lead. Circulation 2005; 111:e304-5.
- McKay M, Pinney S, Gorwara S, Burke EM, Sciacca RR, Apfelbaum M, Mancini D, Itescu S, Rabbani LE. Anti-HLA antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation 2005: 79:1581-1587.
- Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, Mazzeo PA, Pinney SP, Edwards NM, Naka Y. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg 2005; 80:224-228.
- Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Gass A, Pinney SP, Carpentier A, Adams DH. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80:502-506.
- Xydas S, Rosen RS, Pinney S, Hickey KT, Wasserman H, Mancini DM, Naka Y, Oz MC, Bergmann SR, Maybaum S. Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. J Heart Lung Transplant 2005; 24:1976-1979.
- Lubitz SA, Baran DA, Alwarshetty MM, Pinney S, Kaplan S, Chan M, Courtney MC, Lansman SL, Spielvogel D, Gass AL. Long-term results of tacrolimus monotherapy in cardiac transplant recipients. J Heart Lung Transplant 2006; 25:699-706.
- Baran DA, Alwarshetty MM, Alvi S, Arroyo LH, Lubitz S, Pinney S, Gass AL, Zucker MJ. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at 2 transplant centers. J Heart Lung Transplant 2006; 25:1380-1382.
- Lubitz SA, Pinney S, Wisnivesky JP, Gass A, Baran DA. Statin therapy is associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 2007; 26:264-272.
- Anyanwu AC, Fischer GW, Plotkina I, Pinney S, Adams DH. Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg 2007; 84:1405-1407.
- Filsoufi F, Rahmanian PB, Castillo JG, Pinney S, Broumand SR, Adams DH. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. J Heart Lung Transplant 2007; 26:1084-90.
- Nagarsheth NP, Pinney S, Bassily-Marcus A, Anyanwu A, Friedman L, Beilin Y. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg 2008; 107:962-4.
- Shapiro S, Pinney SP, Anyanwu AC, Garcia MJ. An atypical presentation of endomyocardial fibrosis diagnosed by cardiac MRI. Circ Heart Fail 2009;2:77-80.
- Francescone SA, Murphy B, Fallon JT, Hammond K, Pinney S. Tumor lysis syndrome occurring after the administration of rituximab for post-transplant lymphoproliferative disorder. Transplant Proc 2009;41:1946-1948.
- Stevens GR, Lala A, Sanz J, Garcia MJ, Fuster V, Pinney S. Exercise performance in patients with pulmonary hypertension is linked to cardiac magnetic resonance measures. J Heart Lung Transplant 2009;28:899-905.
- Krishan K, Pinney S, Anyanwu AC. Successful use of continuous flow ventricular assist device in a patient with mechanical mitral and aortic valve prosthesis without replacement or exclusion of valves. Interact Cardiovasc Surg 2010;10:325-7.
- Anyanwu AC, Fischer GW, Kalman J, Plotkina I, Pinney S, Adams DH. Preemptive axilloaxillary placement of percutaneous transseptal ventricular assist device to facilitate high-risk reoperative cardiac surgery. Ann Thorac Surg 2010;89:2053-5.
- O’Connor DS, Elmariah S, Aledort LM, Pinney SP. Disseminated intravascular coagulation complicating Epstein-Barr virus infection in a cardiac transplant recipient. Transplant Proc 2010;42:1973-5.
- Krishan K, Pinney S, Anyanwu AC. Management of giant left atrium in patient undergoing left ventricular assist device placement. Ann Thorac Surg 2010; 90:e17-e19.
- Goldstone AB, Chikwe J, Pinney SP, Anyanwu AC, Funt SA, Polanco A, Adams DH. Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation. Am J Cardiol 2011; 107:755-760.
- Garcia-Alvarez A, Fernandez-Friera L, Lau JF, Sawit ST, Mirelis JG, Castillo JG, Pinney S, Anyanwu AC, Fuster V, Sanz J, Garcia MJ. Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devices. J Heart Lung Transplant 2011;30:896-903.
- Kalache S, Dinavahi R, Pinney S, Mehrotra A, Cunningham MW, Heeger PS. Anti-cardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol 2011;187:1023-30.
- Tang GH, Pinney SP, Broumand SR, Adams DH, Anyanwu AC. Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation. Ann Thorac Surg 2011;92:2112-6.
- Krishan K, Nair A, Pinney S, Adams DH, Anyanwu AC. Liberal use of tricuspid valve annuloplasty during left ventricular assist device implantation. Eur J Cardiothorac Surg 2012;41:213-7.
- Sanz J, Garcia-Alvarez A, Fernandez-Friera L, Nair A, Mirelis J, Sawit S, Pinney S, Fuster V. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 2012;98:238-43.
- Pinney SP. Left ventricular assist devices and United Network Organ Sharing heart allocation. J Heart Lung Transplant 2012;31:113.
- Pinney SP, Balakrishnan R, Dikman S, Nair A, Hammond K, Domanski M, Anyanwu AC, DeBoccardo G. Histopathology of renal failure after heart transplantation: a diverse spectrum. J Heart Lung Transplant 2012;31:233-7.
- Pinney SP. Timing isn’t everything: donor heart allocation in the present LVAD era. J Am Coll Cardiol 2012;60:52-3.
- Krishan K, Nair A, Pinney S, Adams D, Anyanwu AC. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era. Artif Organs 2012;36:746-51.
- Krishan K, Pinney S, Anyanwu AC. Successful left ventricular assist device bridge to transplantation in a patient with end-stage heart failure and human immunodeficiency virus. Artif Organs 2012;36:759.
- Tang GH, Kim MC, Pinney SP, Anyanwu AC. Failed repeated thrombolysis requiring left ventricular assist device pump exchange. Catheter Cardiovasc Interv 2013;81:1072-4. PMID 22718366.
- Pawale A, Tang GHL, Milla F, Pinney S, Adams DH, Anyanwu AC. Bench mitral valve repair of donor hearts before orthotopic heart transplantation. Circ Heart Fail 2012;5:e96-7. PMID 23170027.
- Pawale A, Pinney S, Ashley K, Flynn R, Milla F, Anyanwu AC. Implantable left ventricular assist devices as initial therapy for refractory postmyocardial infarction cardiogenic shock. Eur J Cardiothorac Surg 2013;44:213-216. PMID 23364853.
- Kapelusznik L, Varela D, Montgomery SP, Shah AN, Steurer FJ, Rubinstein D, Caplivski, Pinney SP, Turker D, Factor SH. Chagas disease in Latin-American immigrants with dilated cardiomyopathy in New York City. Clin Infect Dis 2013; Epub ahead of print. PMID 23537911.
- Pawale A, Milla F, Pinney S, Anyanwu AC. Successful use of a donor heart with quadricuspid aortic valve for orthotopic heart transplantation. J Card Surg 2013;28:467-8. PMID: 23646902.
- Huprikar S, Bosserman E, Patel G, Moore A, Pinney S, Anyanwu A, Neofytos D, Ketterer D, Striker R, Silveira F, Qvarnstrom Y, Steurer F, Herwaldt B, Montgomery S. Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011. Am J Transplant PMID: 23837488.
- Swartz TH, Huprikar S, LaBombardi V, Pinney S, Anyanwu A, Lee M, Patel G. Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia. Transpl Infect Dis 2013;15:E177-81. PMID: 23902131.
- Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol 2013;6:668-74. PMID: 23873139.
- Pinney SP. Understanding and eliminating racial disparities in transplantation: still a ways to go. J Am Coll Cardiol 2013;62:2316-7. PMID: 23994401.
- Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol 2013;62:2046-72. PMID: 24263073.
- Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Baldwin JT, Pinney S, Rame JE, Miller MA. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the Heartmate II left ventricular assist device. J Heart Lung Transplant 2014;33:12-22. PMID: 24418730.
- Anyanwu AC, Itagaki S, Pinney S, Adams DH. Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy. Eur J Cardiothorac Surg Epub ahead of print. PMID:24623169.
- Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. MOGE(S) nosology in low-to-middle-income countries. Nat Rev Cardiol 2014;11:307. PMID:24663093.
- Scurlock C, Pinney SP, Lin HM, Potenza M, Weiss AJ, Zaidi N, Anyanwu A, Mechanick JI. The Safety of Parenteral Nutrition in Patients Receiving a Ventricular Assist Device. ASAIO J Epub ahead of print. PMID:24658517.
- Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? J Am Coll Cardiol 2014;63:2584-6. PMID: 24768880.
- Bock MJ, Nguyen K, Malerba S, Harrison K, Bagiella E, Gelb BD, Pinney SP, Lytrivi ID. Pediatric cardiac retransplantation: Waitlist mortality stratified by age and era. J Heart Lung Transplant Epub ahead of print. PMID: 25016920.
- Pinney SP. Disparities in heart failure care: now is the time to focus on health care delivery. J Am Coll Cardiol 2014;64:808-10. PMID: 25145525.
- Enriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. J Am Coll Cardiol 2014;64:1883-90. PMID: 25444141.
- Benton CR, Sayer G, Nair AP, Ashley K, Domanski MJ, Henzlova MJ, Anyanwu AC, Pinney SP. Left ventricular assist devices improve functional class without normalizing peak oxygen consumption. ASAIO J PMID: 25635934.
- Pinney SP. RESPONSE: Research networks=shared sacrifice and success. J Am Coll Cardiol 2015; 65:2350-1. PMID: 26217826.
- Goldwater DS, Pinney SP. Frailty in advanced heart failure: a consequence of aging or a separate entity? Clin Med Insights Cardiol 2015;9(Suppl2):39-46. PMID: 26244037.
- Pinney SP, Stevenson LW. Chronic inotropic therapy in the current era: old wines with new pairings. Circ Heart Fail 2015;8:843-6. PMID: 26374915
- Kim B, Tan A, Limketkai BN, Pinney SP, Schiano TD. Comparison of outcome in patients with versus without ascites referred for either cardiac transplantation or ventricular assist device placement. Am J Cardiol 2015;116:1596-600. PMID: 26385517.
- Weerahandi H, Goldstein N, Gelfman LP, Jorde U, Kirkpatrick JN, Marble J, Naka Y, Pinney S, Slaughter MS, Bagiella E, Ascheim DD. Pain and functional status is patients with ventricular assist devices. J Pain Symptom Manage 2016;52(4):483-490. PMID: 27401516.
- Shameer K, Johnson KW, Yahi A, Miotto R, Li LI, Ricks D, Jebakaran J, Kovatch P, Sengupta PP, Gelijns A, Moskovitz A, Darrow B, David DL, Kasarskis A, Tatonetti NP, Pinney S, Dudley JT. Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-strudy using Mount Sinai heart failure cohort. Pac Symp Biocomput 2016;22:276-287. PMID: 27896982.
- Park CS, Akhabue E, Bansal M, Marks J, Salem Omar AM, Pinney SP, Anyanwu A, Chaudhry F, Narula J, Sengupta PP. Dynamic changes in LV radius as a marker of septal configuration for predicting RV failure following LVAD implantation. JACC Cardiovasc Imaging 2017;10:598-599. PMID: 27424242.
- Kusa S, Miller MA, Whang W, Enomoto Y, Panizo JG, Iwasawa J, Choudry S, Pinney S, Gomes A, Langan N, Koruth JS, d’Avila A, Reddy VY, Dukkipati SR. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythm Electrophysiol 2017;10. PMID: 28576780.
- Weerahandi H, Goldstein N, Gelfman LP, Jorde U, Kirkpatrick JN, Meyerson E, Marble J, Naka Y, Pinney S, Slaughter MS, Bagiella E, Ascheim DD. The relationship between psychological symptoms and ventricular assist device implantation. J Pain Symptom Manage 2017;54:870-876. PMID: 2880770.
- Akhabue E, Seok Park C, Pinney S, Anyanwu A, Chaudhry F, Narula J, Nair A, Sengupta PP. Usefulness of speckle tracking strain echocardiography for assessment of risk of ventricular arrhythmias after placement of a left ventricular assist device. Am J Cardiol 2017;120:1578-1583. PMID: 28882335.
- Mancini D, Goldstein D, Taylor S, Chen L, Gass A, DeLair S, Pinney S. Maximizing donor allocation: a review of UNOS region 9 donor heart turn-downs. Am J Transplant 2017;17:3193-3198. PMID: 28898542.
- Maurer MS, Horn E, Reyentovich A, Dickson VV, Pinney S, Goldwater D, Goldstein NE, Jimenez O, Teruya S, Goldsmith J, Helmke S, Yuzefpolskaya M, Reeves GR. Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty? J Am Geriatr Soc;65:2383-2390. PMID: 28940248.
- Sullivan T, Taimur S, Rana M, Patel G, Pinney S, Anyanwu A, Huprikar S. Successful heart transplantation in patients with active Staphylococcus blood stream infection and suspected mechanical circulatory support device infection. Transpl Infect Dis 2017; Epub ahead of print. PMID: 29139180.
- Taimur S, Sullivan T, Rana M, Patel G, Roldan J, Ashley K, Pinney S, Anyanwu A, Huprikar S. Successful heart transplantation in patients with total artificial heart infections. Transpl Infect Dis 2017; Epub ahead of print. PMID: 29110413.
- Pawale A, Schwartz Y, Itagaki S, Pinney S, Adams DH, Anyanwu AC. Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock. J Thorac Cardiovasc Surg 2018;155:1059-1068. PMID: 29274911.
- Cowger JA, Naka Y, Aaronson KD, Horstmanshof D, Gulati S, Rinde-Hoffman D, Pinney S, Adatya S, Farrar DJ, Jorde UP; MOMENTUM 3 Investigators. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. J Heart Lung Transplant 2018;37:15-24. PMID: 29153637.
- Correa A, Patel A, Chauhan K, Shah H, Saha A, Dave M, Poojary P, Mishra A, Annapureddy N, Dalal S, Konstantinidis I, Nimma R, Agarwal SK, Chan L, Nadkarni G, Pinney S. National Trends and Outcomes in Dialysis-Requiring Acute Kidney Injury in Heart Failure: 2002-2013. J Card Fail 2018;24:442-450. PMID: 29730235.
- Rastogi U, Sergie Z, Pinney S, Moss N. Recurrence of eosinophilic granulomatosis with polyangitis after orthotopic heart transplant. Am J Transplant 2018;18:1544-1547. PMID: 29392845.
- Mehra MR, Salerno C, Cleveland JC, Pinney S, Yuzefpolskaya M, Milano CA, Itoh A, Goldstein DJ, Uriel N, Gulati S, Pagani FD, John R, Adamson RM, Bogaev RC, Thohan V, Chuang J, Sood P, Goates S, Silvestry SC. Health care resource use and cost implications in the MOMENTUM3 long-term outcome study: a randomized controlled trial of a magnetically elevated cardiac pump in advanced heart failure. Circulation 2018; 138:1923-1934. PMID: 29807933.
- Pinney SP, Chen JM. Pediatric Ventricular Assist Devices: A Quarter-Century of Support, Yet So Far to Go. J Am Coll Cardiol 2018;72:416-418. PMID: 30025577.
- Gannon MP, Saba SG, Hirsh BJ, Halperin JL, Garcia MJ, Pinney SP, Goldman ME. Three-dimensional echocardiography demonstrates a skewered left ventricular thrombus in a patient with a heart transplant. Echocardiography 2018;35:2117-2120. PMID: 30338540.
- Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Iklé D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC. Early immune biomarkers and intermediate-term outcomes after heart transplant: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant 2019;19:1518-1528. PMID: 30549425.
- Santos-Gallego CG, Garcia-Ropero A, Mancini D, Pinney SP, Contreras JP, Fergus I, Abascal V, Moreno P, Atallah-Lajam F, Tamler R, Lala A, Sanz J, Fuster V, Badimon JJ. Rationale and design of the EMPA-TROPISM Trial (ATRU-4): are the cardiac benefits of empagliflozin independent of its hypoglycemic activity? Cardiovasc Drugs Ther 2019;33:87-95. PMID 30675708.
- Mitter SS, Pinney SP. Left ventricular assist devices for less sick patients: A roadmap for the future or a fork in the road? J Thorac Cardiovasc Surg 2019;158:167-169. PMID: 30879725.
- Pawale A, Itagaki S, Parikh A, Pinney SP, Adams DH, Anyanwu AC. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation. J Thorac Cardiovasc Surg 2019;157:1841-1848. PMID: 31288361
- Khush KK, Patel J, Pinney S, Kao A, Alharethi R, DePasquale E, Ewald G, Berman P, Kanwar M, Hiller D, Yee JP, Woodward RN, Hall S, Kobashigawa J. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Am J Transplant 2019;19:2889-2899. PMID: 30835940.
- Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A; CTOT-11 Study Investigators. Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation. J Am Coll Cardiol 2019;74:36-51. PMID: 31272550.
- Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun Ö, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foà A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol 2019;74:299-311. PMID: 31319912.
- Goldstein NE, Mather H, McKendrick K, Gelfman LP, Hutchinson MD, Lampert R, Lipman HI, Matlock DD, Strand JJ, Swetz KM, Kalman J, Kutner JS, Pinney S, Morrison RS. Improving communication in heart failure patient care. J Am Coll Cardiol 2019;74:1682-1692. PMID: 31558252.
- Moayedi Y, Fan CS, Miller RJH, Tremblay-Gravel M, Posada JGD, Manlhiot C, Hiller D, Yee J, Woodward R, McCaughan JA, Shullo MA, Hall SA, Pinney S, Khush KK, Ross HJ, Teuteberg JJ. Gene expression profiling and racial disparities in outcomes after heart transplantation. J Heart Lung Transplant 2019;38:820-829. PMID: 31201087.
- Cagliostro M, Bromley A, Ting P, Donehey J, Ferket B, Parks K, Palumbo E, Mancini D, Anyanwu A, Pawale A, Pinney S, Moss N, Lala A. Standardized Use of the Stanford Integrated Psychosocial Assessment for Transplantation in LVAD Patients. J Card Fail 2019;25:735-743. PMID: 31220624.
- Farr M, Truby LK, Lindower J, Jorde U, Taylor S, Chen L, Gass A, Stevens G, Reyentovich A, Mancini D, Arcasoy S, Delair S, Pinney S. Potential for Donation after Circulatory Death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset. Am J Transplant PMID: 31529766.
- Bhatt PJ, Ali M, Rana M, Patel G, Sullivan T, Murphy J, Pinney S, Anyanwu A, Huprikar S, Taimur S. Infections Due To Multidrug-Resistant Organisms Following Heart Transplantation: Epidemiology, Microbiology, And Outcomes. Transpl Infect Dis 2019;e13215. doi:10.1111/tid.13215. PMID 31765045.
- Park C, Otobo E, Ullman J, Rogers J, Fasihuddin F, Garg S, Kakkar S, Goldstein M, Chandrasekhar SV, Pinney S, Atreja A. Impact on Readmission Reduction Among Heart Failure Patients Using Digital Health Monitoring: Feasibility and Adoptability Study. JMIR Med Inform. 2019;7(4):e13353. Published 2019 Nov 15. doi:10.2196/13353. PMID: 31730039.
- Cowger JA, Shah P, Pagani FD, Grafton G, Stulak J, Chamogeorgakis T, Lanfear D, Nemeh H, Pinney S. Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis. J Heart Lung Transplant [Epub ahead of print] PMID: 31831209.
- Veronese G, Ammirati E, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun OÖ, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foà A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG. Viral genome search in myocardium of patients with fulminant myocarditis. Eur J Heart Fail [Epub ahead of print] PMID: 31926056.
- Saxena A, Garan AR, Kapur NK, O’Neill WW, Lindenfeld J, Pinney SP, Uriel N, Burkhoff D, Kern M. Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020 Apr 07; 141(14):1184-1197. PMID: 32250695.
- Chau VQ, Oliveros E, Mahmood K, Singhvi A, Lala A, Moss N, Gidwani U, Mancini DM, Pinney SP, Parikh A. The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support. JACC Case Rep. 2020 Apr 08. PMID: 32292915.
- Lala A, Rowland JC, Ferket BS, Gelijns AC, Bagiella E, Pinney SP, Moskowitz AJ, Miller MA, Pagani FD, Mancini DM. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure. JAMA Cardiol. 2020 Apr 15. PMID: 32293643.
- Lala A, Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Januzzi J, Mancini DM, Fuster V. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. medRxiv. 2020 Apr 24. PMID: 32511658.
- Brailovsky Y, Oliveros E, Pinney S. When the Neighbor Is at Fault: Constrictive Pericarditis After Bilateral Lung Transplantation. JACC: Case Reports June 01, 2020, 2 (6) 943-945; DOI: 10.1016/j.jaccas.2020.04.047.
- Barghash MH, Pinney SP. Heart Failure in the COVID-19 Pandemic: Where Has All New York’s Congestion Gone? J Card Fail. 2020 Jun; 26(6):477-478. PMID: 32389608.
- Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. J Am Coll Cardiol. 2020 Jun 05. PMID: 32517963.
- Kwok IB, Mather H, McKendrick K, Gelfman L, Hutchinson MD, Lampert RJ, Lipman HI, Matlock DD, Swetz KM, Kalman J, Pinney S, Morrison RS, Goldstein NE. Evaluation of a Novel Educational Intervention to Improve Conversations About Implantable Cardioverter-Defibrillators Management in Patients with Advanced Heart Failure. J Palliat Med 2020;23:1619-1625. PMID: 32609036.
- Singhvi A, Barghash M, Lala A, Mitter SS, Parikh A, Oliveros E, Rollins BM, Brunjes DL, Alvarez-Garcia J, Johnston E, Ryan K, Itagaki S, Moss N, Pinney SP, Anyanwu A, Mancini D. Challenges in Heart Transplantation during COVID-19: A Single Center Experience. J Heart Lung Transplant 2020;39:894-903. PMID: 32891266.
- Mahmood K, Rashed ER, Oliveros E, Chau VQ, Hermle T, Jacobs S, Lala A, Singhvi A, Parikh A, Pinney SP. Predisposition or Protection? COVID-19 in a Patient on LVAD Support With HIV/AIDS. JACC: Case Reports 2020;2:1337-1341. PMID: 32835275.
- Parikh AG, Pinney SP. Transcatheter mitral valve repair in functional mitral regurgitation: who will benefit? Ann Cardiothorac Surg 2020. doi: 10.21037/acs-2020-mv-14.
- Oliveros E, Mahmood K, Mitter S, Pinney SP, Lala A. Pulmonary artery pressure monitoring during the COVID-19 pandemic in New York City. J Card Fail 2020. Doi: 10.1016/j.cardfail.2020.08.003. PMID 32805377.
- Berg DD, Braunwald E, DeVore AD, Lala A, Pinney SP, Duffy CI, Gurmu Y, Velazquez EJ, Morrow DA. Efficacy and safety of sacubitril/valsartan by dose level achieved in the PIONEER-HF Trial. JACC Heart Fail 2020; doi: 10.1016/j.jchf.2020.06.008. PMID: 32800511.
- Gelfman LP, Sudore RL, Mather H, McKendrick K, Hutchinson MD, Lampert RJ, Lipman HI, Matlock DD, Swetz KM, Pinney SP, Morrison RS, Goldstein NE. Prognostic awareness and goals of care discussions among patients with advanced heart failure. Circ Heart Fail 2020 Sep;13(9):e006502. doi: 10.1161/CIRCHEARTFAILURE.119.006502. PMID: 32873058.
- Chau VQ, Giustino G, Mahmood K, Oliveros E, Neibart E, Oloomi M, Moss N, Mitter SS, Contreras JP, Croft L, Serrao G, Parikh AG, Lala A, Trivieri MG, LaRocca G, Anyanwu A, Pinney SP, Mancini DM. Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Heart Fail. 2020 Aug 26. doi: 10.1161/CIRCHEARTFAILURE.120.007485. PMID: 32844662.
- Bansal A, Goldstein D, Schettle S, Pepitone S, Lima B, Pham DT, Cowger J, Schubert A, Pinney SP. Institutional preparedness strategies for heart failure, durable left ventricular assist device, and heart transplant patients during the Coronavirus Disease 2019 (COVID-19) pandemic. J Thorac Cardiovasc Surg 2021;162:131-135. PMID: 32994096.
- Oliveros E, Mahmood K, Yammine M, Chau V, Fox A, Ahmed S, Anyanwu A, Pinney S, Mancini D, Lala A, Barghash M. Rapid Deterioration of Hospital-Acquired COVID-19 in a Patient on Extracorporeal Left Ventricular Assist Support. Heart Lung 2020;49:808-811. PMID: 33010519.
- Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, Rosenson RS, Fuster V. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol 2020;76:1999-2010. PMID: 33092736.
- Giustino G, Pinney SP, Lala A, Reddy VY, Johnston-Cox HA, Mechanick JI, Halperin JL, Fuster V. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2011-2023. PMID: 33092737.
- Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2024-2035. PMID: 33092738.
- Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, Danilov T, Kukar N, Shaban N, Kini A, Camaj A, Bienstock SW, Rashed ER, Rahman K, Oates CP, Buckley S, Elbaum LS, Arkonac D, Fiter R, Singh R, Li E, Razuk V, Robinson SE, Miller M, Bier B, Donghi V, Pisaniello M, Mantovani R, Pinto G, Rota I, Baggio S, Chiarito M, Fazzari F, Cusmano I, Curzi M, Ro R, Malick W, Kamran M, Kohli-Seth R, Bassily-Marcus AM, Neibart E, Serrao G, Perk G, Mancini D, Reddy VY, Pinney SP, Dangas G, Blasi F, Sharma SK, Mehran R, Condorelli G, Stone GW, Fuster V, Lerakis S, Goldman ME. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol 2020;76:2043-2055. PMID: 33121710.
- Santos-Gallego CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, Mancini D, Pinney S, Macaluso F, Sartori S, Roque M, Sabatel-Perez F, Cordero AR, Zafar MU, Fergus I, Atallah-Lajam F, Contreras JP, Varley C, Moreno PR, Abascal VM, Lala A, Tamler R, Sanz J, Fuster V, Badimon JJ; EMPA-TROPISM (ATRU-4) investigators. Randomized trial of empagliflozin in non-diabetic patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 2021;77:243-255. PMID: 33197559.
- Kanwar MK, Khush KK, Pinney S, Sherman C, Hall S, Teuteberg J, Uriel N, Kobashigawa J. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients. J Heart Lung Transplant 2021;40:101-107. PMID: 33341360.
- Lala A, Januzzi J, Pinney SP, Mancini DM, Fuster V. Reply: What happened to electrocardiogram as a screening test to recognize cardiovascular complications in COVID-19 patients? J Am Coll Cardiol 2020;76:2800-2801. PMID: 33272379.
- Lala A, Barghash MH, Giustino G, Alvarez-Garcia J, Konje S, Parikh A, Ullman J, Keith B, Donehey J, Mitter SS, Trivieri MG, Contreras JP, Burkhoff D, Moss N, Mancini DM, Pinney SP. Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions. ESC Heart Fail 2021;8:1047-1054. PMID 33336881.
- Parikh AG, Pinney SP. Transcatheter mitral valve repair in functional mitral regurgitation: who will benefit? Ann Cardiothorac Surg 2021;10:161-163. PMID: 33575187.
- Henry M, Abutaleb A, Jeevanandam V, Smith H, Belkin M, Husain A, Pinney S, Ota T, Lang RM, Addetia K. Anatomic Description of Tricuspid Apparatus Interference From Implantable Intracardiac Devices. JACC Cardiovasc Imaging. 2021 Feb 2:S1936-878X(20)31107-4. PMID: 33582061.
- Belkin MN, Alenghat FJ, Besser SA, Nguyen AB, Chung BB, Smith BA, Kalantari S, Sarswat N, Blair JEA, Kim GH, Pinney SP, Grinstein J. Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial. ESC Heart Fail. 2021;8:1522-1530. PMID: 33595923.
- Symalla T, Peev MP, Song T, Naftel D, Myers S, Koehl D, Cantor RS, Pinney S, Jeevanandam V. STS INTERMACS Database: The Key to Conduct Single-arm Trials in Advanced Heart Failure Patients. Ann Thorac Surg 2021; Apr 27:S0003-4975(21)00757-8. doi: 10.1016/j.athoracsur.2021.04.045. Epub ahead of print. PMID: 33930360.
- Amir O, Anker SD, Gork I, Abraham WT, Pinney SP, Burkhoff D, Shallom ID, Haviv R, Edelman ER, Lotan C. Feasibility of remote speech analysis in evaluation of dynamic fluid overload in heart failure patients undergoing haemodialysis treatment. ESC Heart Fail 2021;8:2467-2472. PMID: 33955187.
- Belkin MN, Kalantari S, Kanelidis AJ, Miller T, Smith BA, Besser SA, Tehrani D, Chung BB, Nguyen A, Sarswat N, Blair JEA, Burkhoff D, Sayer G, Pinney SP, Uriel N, Kim G, Grinstein J. Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail 2021;27:1045-1052. PMID: 34048919.
- Gelfman LP, Mather H, McKendrick K, Wong AY, Hutchinson MD, Lampert RJ, Lipman HI, Matlock DD, Swetz KM, Pinney SP, Morrison RS, Goldstein NE. Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure. J Card Fail 2021;27(6):700-705. PMID: 34088381.
- Cowger JA, Estep JD, Rinde-Hoffman DA, Givertz MM, Anderson AS, Jacoby D, Chen L, Brieke A, Mahr C, Hall S, Ewald GA, Dirckx N, Baker AT, Pinney SP. Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3TM. ASAIO J 2021 Jun 25. doi: 10.1097/MAT.0000000000001497. PMID: 34172641.
- Nishida H, Song T, Onsager D, Nguyen A, Grinstein J, Chung B, Smith B, Kalantari S, Sarswat N, Kim G, Pinney S, Jeevanandam V, Ota T. Proximal ascending aorta size is associated with the incidence of de novo aortic insufficiency with left ventricular assist device. Heart Vessels 2021; Sep 28. doi: 10.1007/s00380-021-01946-4. Epub ahead of print. PMID: 34585275.
- Belkin MN, Alenghat FJ, Besser SA, Pinney SP, Grinstein J. Improved Prognostic Performance of Cardiac Power Output with Right Atrial Pressure: A Sub-Analysis of the ESCAPE Trial. J Card Fail. 2021 Nov 10:S1071-9164(21)00440-1. doi: 10.1016/j.cardfail.2021.11.001. Epub ahead of print. PMID: 34774746.
- Parikh A, Halista M, Raymond S, Feinman J, Mancini D, Mitter S, Barghash M, Trivieri M, Contreras J, Taimur S, Roldan J, Murphy J, Pawale A, Anyanwu A, Moss N, Lala A, Pinney S. Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes. Am J Cardiol. 2021 Dec 1;160:67-74. doi: 10.1016/j.amjcard.2021.08.044. Epub 2021 Oct 3. PMID: 34615608.
- Belkin MN, Kagan V, Labuhn C, Pinney SP, Grinstein J. Physiology and Clinical Utility of HeartMate Pump Parameters. J Card Fail. 2021 Dec 31:S1071-9164(21)00481-4. doi: 10.1016/j.cardfail.2021.11.016. Epub ahead of print. PMID: 34980564.
- Amir O, Abraham WT, Azzam ZS, Berger G, Anker SD, Pinney SP, Burkhoff D, Shallom ID, Lotan C, Edelman ER. Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure. JACC Heart Fail. 2022 Jan;10(1):41-49. doi: 10.1016/j.jchf.2021.08.008. Epub 2021 Dec 8. PMID: 34969496.
- Imamura T, Kinugawa K, Narang N, Nishida H, Pinney S, Jeevanandam V, Ota T. Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Int Heart J. 2022;63(1):56-61. PMID: 35095077.
- Nishida H, Song T, Onsager D, Nguyen A, Grinstein J, Chung B, Smith B, Kalantari S, Sarswat N, Kim G, Pinney S, Jeevanandam V, Milner R, Ota T. Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jan 5:S0890-5096(21)01052-9. doi: 10.1016/j.avsg.2021.12.078. Epub ahead of print. PMID: 34995740.
- Chau VQ, Feinman J, Fullin K, Mahmood K, Oliveros E, Mitter SS, Pinney SP, Mancini DM, Lala A, Moss N. De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices. Transpl Immunol. 2022 Mar 9;72:101567. doi: 10.1016/j.trim.2022.101567. Epub ahead of print. PMID: 35278648.
- Leven EA, Kurdi AT, Govindarajulu U, Schiano T, Pinney S, Crismale JF. Child-Turcotte-Pugh versus MELD-XI identify distinct high-risk populations for heart transplantation following ventricular assist device placement. Clin Transplant. 2022 Feb 21:e14617. doi: 10.1111/ctr.14617. Epub ahead of print. PMID: 35191097.
- Kanwar MK, Pagani FD, Mehra MR, Estep JD, Pinney SP, Silvestry SC, Uriel N, Goldstein DJ, Long J, Cleveland Jr JC, Kormos RL, Wang A, Chuang J, Cowger JA. Center Variability in Patient Outcomes following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. Journal of Cardiac Failure (2022). DOI: https://doi.org/10.1016/j.cardfail.2022.04.006.
- Blum M, Gelfman LP, McKendrick K, Pinney SP, Goldstein NE. Enhancing Palliative Care for Patients With Advanced Heart Failure Through Simple Prognostication Tools: A Comparison of the Surprise Question, the Number of Previous Heart Failure Hospitalizations, and the Seattle Heart Failure Model for Predicting 1-Year Survival. Front Cardiovasc Med. 2022 Apr 11;9:836237. PMID: 35479267.
- Nishida H, Salerno C, Onsager D, Song T, Nguyen A, Grinstein J, Chung B, Smith B, Kalantari S, Sarswat N, Kim G, Pinney S, Jeevanandam V, Ota T. Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 Apr 23. doi: 10.1002/ehf2.13947. Epub ahead of print. PMID: 35460200.
Consensus Statements / Guidelines:
- Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009;28:213-25.
- Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-956. (Task force 3)*
- Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant 2014;33:327-40.
- Kobashigawa J, Teuteberg J, Colvin M, et al. Proceedings of the AST heart allocation meeting at the American Transplant Congress, Philadelphia, Pennsylvania, May 4, 2015. Clin Transplant 2016;30:641-8. PMID: 27000519.
- Kusne S, Mooney M, Danziger-Isakov L, Kaan A, Lund LH, Lyster H, Wieselthaler G, Aslam S, Cagliostro B, Chen J, Combs P, Cochrane A, Conway J, Cowger J, Frigerio M, Gellatly R, Grossi P, Gustafsson F, Hannan M, Lorts A, Martin S, Pinney S, Silveira FP, Schubert S, Schueler S, Strueber M, Uriel N, Wrightson N, Zabner R, Huprikar S. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant 2017; PMID: 28781010.
- Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Report from the American Society of Transplantation on Frailty in Solid Organ Transplantation. Am J Transplant 2019;19: 984-994. PMID: 30506632.
- Givertz MM, DeFilippis EM, Colvin M, Darling CE, Elliott T, Hamad E, Hiestand BC, Martindale JL, Pinney SP, Shah KB, Vierecke J, Bonnell M. HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices. J Card Fail 2019;25:494-515. PMID: 31271866.
- Givertz MM, DeFilippis EM, Colvin M, Darling CE, Elliott T, Hamad E, Hiestand BC, Martindale JL, Pinney SP, Shah KB, Vierecke J, Bonnell M. HFSA/SAEM/ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices. J Heart Lung Transplant 2019;38:677-698. PMID: 31272557.
- Editors, Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG; Contributing Authors, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J; Reviewers, Schueler S, D’Alessandro DA. American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Thorac Cardiovasc Surg PMID: 31983522 and J Heart Lung Transplant 2020 Mar;39(3):187-219. PMID: 31983666.
- Darling CE, Martindale JL, Hiestand BC, Bonnell M, Colvin M, DeFilippis EM, Elliott T, Hamad E, Pinney SP, Shah KB, Vierecke J, Givertz MM. An Emergency Medicine-focused Summary of the HFSA/SAEM/ISHLT Clinical Consensus Document on the Emergency Management of Patients With Ventricular Assist Devices. Acad Emerg Med. 2020 Jul; 27(7):618-629. PMID: 32176420.
- Kobashigawa J, Shah P, Joseph S, Olymbios M, Bhat G, Dhital K, Eisen H, Kransdorf E, Patel J, Skora R, Pinney S, Wilson ME, Hall S; Heart Frailty Workgroup. Frailty in Heart Transplantation: Report from the Heart Workgroup of a Consensus Conference on Frailty. Am J Transplant 2021;21:636-644. PMID: 32659872.
- Kobashigawa JA, Hall S, Farr M, Blumberg E, Michael Borkon A, Colvin M, Copeland H, Eisen H, Johnson M, Jorde U, Khush K, Kirklin JK, Patel J, Pinney S, Saadaeijahromi H, Schold JD, Stehlik J; Consensus Conference Participants. Proceedings from the metrics forum in heart transplantation for performance monitoring. Am J Transplant. 2021 Dec 6. doi: 10.1111/ajt.16901. Epub ahead of print. PMID: 34866328.
Review Articles:
- Pinney SP, Rabbani LE. Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors. J Thromb Thrombolysis 2001; 11:11-17.
- Pinney SP, Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention and treatment. Curr Opin Cardiol 2004; 19:170-176.
- Pulerwitz T, Rabbani LE, Pinney SP. A rationale for the use of anticoagulation in heart failure management. J Thromb Thrombolysis 2004; 17:87-93.
- Gehi AK, Pinney SP, Gass A. Recent diagnostic and therapeutic innovations in heart failure management. Mt Sinai J Med 2005; 72:176-184.
- Winslow RD, Pinney S, Fuster V. Impact of implantable cardioverter-defibrillator trials on clinical management of patients with heart failure. Nat Clin Pract Cardiovasc Med 2006; 3:86-93.
- Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present and future. Mt Sinai J Med 2006; 73:840-851.
- Harrison M, Anyanwu A, Pinney SP. Management of stage D heart failure. Mt Sinai J Med 2009;76:404-414.
- Pinney SP. The role of tricuspid valve repair and replacement in right heart failure. Curr Opin Cardiol 2012;27:288-95.
- Murphy L, Pinney SP. Clinical outcomes following heart transplantation. Mt Sinai J Med 2012;79:317-29.
- Milla F, Pinney SP, Anyanwu AC. Indications for heart transplantation in current era of left ventricular assist devices. Mt Sinai J Med 2012;79:305-16.
- Dutt DP, Pinney SP. Clinical variability within the INTERMACS 1 profile: implications for treatment options. Curr Opin Cardiol 2014;29:244-9. PMID: 24694386.
- Gandhi PU, Pinney S. Management of chronic heart failure: biomarkers, monitors and disease management programs. Ann Glob Health 2014;80:46-54. PMID: 24751564.
- Pinney SP. Left Ventricular Assist Devices: The adolescence of a disruptive technology. J Card Fail 2015;21:824-34. PMID: 26318347.
- Lala A, Pinney SP. Recognizing pulmonary hypertension and right ventricular dysfunction in heart failure. Prog Cardiovasc Dis 2016;58:416-24. PMID: 26780235.
- Pinney SP, Anyanwu AC, Lala A, Teuteberg JJ, Uriel N, Mehra MR. Left ventricular assist devices for lifelong support. J Am Coll Cardiol 2017;69:2845-2861. PMID 28595702.
- Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR. The clinical use of ivabradine. J Am Coll Cardiol 2017;70:1777–84. PMID 28958335.
- Barghash MH, Pinney SP. Contemporary treatment of heart failure. Card Electrophysiol Clin 2019;11:21-37. PMID 30717850.
- Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, Gurley J, Nelson K, Malyala R, Panjrath GS, Zwischenberger JB, Pinney SP. Venoarterial ECMO for Adults: JACC Scientific Expert Panel. J Am Coll Cardiol 2019;73:698-716. PMID: 30765037.
- Givertz MM, DeFilippis EM, Landzberg MJ, Pinney SP, Woods RK, Valente AM. Advanced heart failure therapies for adults with congenital heart disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;74(18):2295-2312. PMID: 31672187.
- Barghash MH, Pinney SP. Heart Retransplantation: Candidacy, Outcomes, and Management. Curr Transplant Rep. 2020; 7(1):12-17. PMID: 32435573.
- Mitter SS, Pinney SP. Advances in the Management of Acute Decompensated Heart Failure. Med Clin North Am. 2020 Jul; 104(4):601-614. PMID: 32505255.
- Abraham WT, Bensimhon D, Pinney SP, Feitell SC, Peacock WF, Amir O, Burkhoff D. Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial. ESC Heart Fail 2021;8:3472-3482. PMID: 34390219.
- Varshney AS, DeFilippis EM, Cowger JA, Netuka I, Pinney SP, Givertz MM. Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar. J Am Coll Cardiol. 2022 Mar 22;79(11):1092-1107. doi: 10.1016/j.jacc.2022.01.017. PMID: 35300822.
Book Chapters:
- Pinney SP, Mancini DM. Myocarditis and specific cardiomyopathies—endocrine
disease and alcohol. In: Fuster V, Alexander RW, O’Rourke RA, Roberts R, King
SB, Nash IS, Prystowsky EN, eds. Hurst’s The Heart, 11th edition. New York,
NY: McGraw-Hill; 2004:1949-1974.
- Pinney SP. Post transplant management. In: Edwards NM, Chen JM, Mazzeo PA,
eds. Columbia-Presbyterian Manual of Cardiac Transplantation. Totowa, NJ:
Humana Press; 2004:123-157.
- Pinney SP, Mancini DM. Inflammatory cardiomyopathies—endocrine disease and alcohol. In: O’Rourke RA, Fuster V, Alexander RW, Roberts R, King SB,
Prystowsky EN, Nash IS, eds. Hurst’s The Heart: manual of cardiology, 11th
edition. New York, NY: McGraw-Hill; 2005:467-478.
- Pinney SP, Mancini DM. Myocarditis and specific cardiomyopathies. In: Fuster
V, et al., eds. Hurst’s The Heart, 12th edition. New York, NY: McGraw-Hill; 2008:863-81.
- Lau JF, Nair A, Pinney S, Smith DA, Caplivski D. Cardiovascular comorbidities. In: Mullen MP, Caplivski D, eds. HIV and Comorbidities: a case-based approach to diagnosis and management. New York, NY: Oxford University Press; 2008:81-106.
- Pinney SP, Nair AP, Mancini DM. Myocarditis and specific cardiomyopathies. In: O’Rourke RA, Walsh RA, Fuster V, eds. Hurst’s The Heart: manual of cardiology, 12th edition. New York, NY: McGraw-Hill; 2009:506-517.
- Pinney SP, Mancini DM. Myocarditis and specific cardiomyopathies. In: Fuster V, et al., eds. Hurst’s The Heart, 13th edition. New York, NY: McGraw-Hill; 2011:876-93.
- Sayer G, Pinney S. Acute decompensated heart failure. In: Dunn A, Kathuria N, Klotman P, eds. Essentials of Hospital Medicine: A Practical Guide for Clinicians. Hackensack, NJ:World Scientific; 2012:205-220.
- Domanski MJ, Halushka M, Pinney S. Endomyocardial biopsy in the failing heart. In: Domanski M, Mehra MR, Pfeffer M, eds. Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation. Oxford University Press; 2016:92.
- Lipson N, Pinney SP. Rejection surveillance, type and treatment. In: Domanski M, Mehra MR, Pfeffer M, eds. Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation. Oxford University Press; 2016:307.
- Chaanine AH, Pinney SP. Mechanical circulatory support as a bridge to heart transplantation. In: Eisen H, ed. Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care. London: Springer-Verlag; 2017:639-664.
- Arbustini E, Agozzino M, Favalli V, Pinney S, Narula J. Myocarditis. In: Fuster V, Harrington RA, Narula J, Eapen ZJ, eds. Hurst’s The Heart: 14th edition. New York, NY: McGraw Hill Professional; 2017:1528.
- Moss N, Pinney SP. Mechanical circulatory support in the Cardiac Care Unit. In: Herzog E, ed. Herzog’s CCU Book. Philadelphia, PA: Wolters Kluwer Health;2018.
- Adler EA, Contreras J, Pinney SP. Selection and care of the heart transplant patient. In: Herzog E, ed. Herzog’s CCU Book. Philadelphia, PA: Wolters Kluwer Health;2018.
- Holman WL, Kociol RD, Pinney S. Postoperative VAD management: operating room to discharge and beyond. In: Kirklin JK, Rogers JG, eds. Mechanical Circulatory Support: A companion to Braunwald’s Heart Disease. Philadelphia, PA: Elsevier; 2020:131-143.
- Arbustini E, Di Toro A, Urtis M, Pinney S, Narula J. Myocarditis. In: Fuster V, Narula J,
Vaishnava P, Leon MB, Callans DJ, Rumsfeld JS, Poppas A, eds. Fuster & Hurst’s The
Heart, 15th edition. New York, NY: McGraw-Hill; 2022:1415-1461.
- Pinney SP, Giustino G, Mechanick JI. Cardiovascular Manifestations of COVID-19. In:
Fuster V, Narula J, Vaishnava P, Leon MB, Callans DJ, Rumsfeld JS, Poppas A, eds.
Fuster & Hurst’s The Heart, 15th edition. New York, NY: McGraw-Hill; 2022:2307-
2333.
Abstracts (Partial list previous 2 years):
- A. Cowger, J.D. Estep, D.A. Rinde-Hoffman, M.M. Givertz, A.S. Anderson, D. Jacoby, L. Chen, A. Brieke, C. Mahr, S. Hall, G.A. Ewald, A. Baker, J. Chuang, S.P. Pinney. Variability in Blood Pressure Assessment in Patients Supported with HeartMate 3. J Heart Lung Transplant 2020, Volume 39, Issue 4, S156 – S157.
- Kanwar, S. Pinney, P. Shah, and J. Kobashigawa. Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap Registry. J Heart Lung Transplant 2020, Volume 39, Issue 4, S83 – S84.
- Rahman, D. Dunn, E. Baneman, T. Sullivan, R. Fuller, S. Jacobs, S. Pinney, M. Barghash, M. Rana, S. Taimur. Strongyloides Screening in Heart Transplant Candidates. J Heart Lung Transplant 2020, Volume 39, Issue 4, S482 – S483.
- H. Barghash, S. Taimur, M. Rana, J. Behar, A. Lala, S.S. Mitter, N. Moss, S.P. Pinney, D. Mancini. Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience. J Heart Lung Transplant 2020, Volume 39, Issue 4, S204.
- Alvarez-Garcia, A. Lala, J. Ullman, A. Damato, D. Brunjes, S. Pinney. Remote Dielectric Sensing (ReDS) for a Safe Discharge in Patients with Acutely Decompensated Heart Failure: Rationale and Design of the ReDS-SAFE HF Study. J Heart Lung Transplant 2020, Volume 39, Issue 4, S240.
- DePasquale E, Kobashigawa J, Pinney S, Khush K. dd-cfDNA as a risk factor for initiating de-novo donor specific antibodies in heart transplantation. Am J Transplant 2020; 20(Suppl 3):663.
- Leven E, Kurdi AT, Pinney S, Schiano T. Child-Turcotte-Pugh Class at Transplantation Predicts Mortality after Heart Transplantation Following Left Ventricular Assist Device Placement. Am J Transplant 2020; 20(Suppl 3):772.
- Amir O, Ben-Gal T, Weinstein JM, Murnikas D, Iakobishvili Z, Yosefy C, Shochat MK, Dragu R, Ouzan E, Azzam ZS, Lotan C, Edelman ER, Anker SD, Shallom ID, Haviv R, Pinney SP, Burkhoff D, Abraham WT. A Novel Approach Using Remote Speech Analysis in Chronic Ambulatory Heart Failure Patients Allows Early Detection of Clinical Decompensation Leading to Hospitalization. J Card Fail 2020;26(10_Suppl):S89.
- Santos-Gallego CG, Requena-Ibanez JA, Vargas A, Garcia-Ropero A, Rodriguez-Cordero A, Pinney S, Mancini DM, Lala A, Contreras JP, Moreno PR, Sanz J, Fuster V, Badimon JJ. The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial. Circulation 2020;142(Suppl_3).
- Santos-Gallego CG, Requena-Ibanez JA, Vargas A, Garcia-Ropero A, Rodriguez-Cordero A, Pinney S, Mancini DM, Lala A, Contreras JP, Moreno PR, Sanz J, Fuster V, Badimon JJ. The SGLT2 Inhibitor Empagliflozin Ameliorates Interstitial Myocardial Fibrosis and Aortic Stiffness in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial. Circulation 2020;142(Suppl_3).
- A. Siddiqi, P.S. Combs, C. Stonebraker, E. Gonzales, S. Mirzai, A. Lee, J. Cruz, K. Hu, T. Symalla, C. LaBuhn, S. Pinney, V. Jeevanandam. Jehovah’s Witness Patients “Going the Extra Mile” for Bloodless LVAD Implantation. J Heart Lung Transplant 2021, Volume 40, Issue 4, S386.
- A. Siddiqi, P.S. Combs, S. Pinney, V. Jeevanandam. Seasonal Variation in Epistaxis Recurrence and Mortality in Left Ventricular Assist Device Patients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S391.
- Rodgers, C. Raikarr, E. Kruse, P. Combs, J. Mazurski, J. Cruz, S. Lupo, K. Hu, B. Smith, A.B. Nguyen, B. Chung, S. Kalantari, N. Sarswat, G. Kim, J. Grinstein, N. Uriel, C. Labuhn, D. Onsager, T. Song, N. Hibino, T. Ota, S. Pinney, V. Jeevanandam. A Signal in the Noise: Noninvasive Acoustical Evaluation of Continuous Flow Left Ventricular Assist Device. J Heart Lung Transplant 2021, Volume 40, Issue 4, S414 – S415.
- Miller, M. Belkin, U. Siddiqi, D. Rodgers, A. Kanelidis, N. Uriel, T. Song, T. Ota, S. Kalantari, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Cardiac Power Output and Cardiac Power Efficiency Show Prognostic Value in LVAD Patients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S418 – S419.
- Miller, M. Belkin, U. Siddiqi, A. Kanelidis, D. Rodgers, N. Uriel, T. Song, T. Ota, S. Kalantari, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Mean Arterial Pressure is Not Associated with Hemocompatibility-Related Outcomes in LVAD Patients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S433.
- A. Siddiqi, P.S. Combs, S. Pinney, V. Jeevanandam. A Propensity Score Matched Comparison of Heartmate 3 and HeartWare HVAD Epistaxis Outcomes. J Heart Lung Transplant 2021, Volume 40, Issue 4, S435.
- N. Belkin, T. Imamura, A. Kanelidis, M. Henry, T. Fujino, V. Kagan, K. Meehan, J. Okray, S. Creighton, C. LaBuhn, T. Song, T. Ota, V. Jeevanandam, A.B. Nguyen, B.B. Chung, B.A. Smith, S. Kalantari, J. Grinstein, N. Sarswat, S.P. Pinney, G. Sayer, G. Kim, N. Uriel. Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients: The TOLVAD Study. J Heart Lung Transplant 2021, Volume 40, Issue 4, S446.
- Bole, D. Rodgers, B. Smith, A. Nguyen, B. Chung, S. Kalantari, N. Sarswat, G. Kim, T. Song, T. Ota, V. Jeevanandam, S. Pinney, J. Grinstein. Estimated versus Actual Oxygen Consumption in Patients Supported with LVADs. J Heart Lung Transplant 2021, Volume 40, Issue 4, S449 – S450.
- Nazeer, N. Sarswat, B. Smith, J. Grinstein, S. Kalantari, A. Nguyen, G. Kim, S. Pinney, B. Chung. Features of Posterior Reversible Encephalopathy Syndrome 3 Days Following Tacrolimus Initiation in Heart Transplant Recipient. J Heart Lung Transplant 2021, Volume 40, Issue 4, S473 – S474.
- Mehta, N. Sarswat, B. Smith, S. Kalantari, A. Nguyen, B. Chung, G. Upadhyay, R. Kalathiya, G. Kim, V. Jeevanandam, S. Pinney, J. Grinstein. Beck’s Quadrad? A Rare Case of Pericardial Tamponade Presenting as Transient Pre-Excitation Early after Cardiac Transplantation. J Heart Lung Transplant 2021, Volume 40, Issue 4, S475.
- Dela Cruz, E. Littmann, R. Nayak, C. Lehmann, R. Keskey, T. Baker, H. Lin, A. Bennett, G. Kim, S. Pinney, E. Pamer, and A.B. Nguyen. The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study. J Heart Lung Transplant 2021, Volume 40, Issue 4, S25.
- Nazeer, S. Pinney, B. Smith, B. Chung, P. Mcmullen, A. Nguyen, J. Grinstein, N. Sarswat, G. Kim, S. Kalantari. Dueling Malignancies: A Rare Instance of Both Kaposi Sarcoma and Cardiac Plasmacytoma in a Patient Post OHT. J Heart Lung Transplant 2021, Volume 40, Issue 4, S487.
- Bole, D. Rodgers, B. Smith, A. Nguyen, B. Chung, S. Kalantari, N. Sarswat, G. Kim, T. Song, T. Ota, V. Jeevanandam, E. Kruse, C. Kordeck, C. Kramer, S. Pinney, J. Grinstein. Simultaneous Multi-Vascular Bed Imaging in a Patient Supported by a Continuous-Flow LVAD. J Heart Lung Transplant 2021, Volume 40, Issue 4, S529.
- N. Belkin, A.P. Shah, S. Nathan, R. Kalathiya, T. Song, T. Ota, V. Jeevanandam, A.B. Nguyen, B.B. Chung, B.A. Smith, S. Kalantari, N. Sarswat, G. Kim, S.P. Pinney, J. Grinstein. Performing under Pressure: Invasive Hemodynamics to Diagnose and Guide Treatment of LVAD Outflow Graft Stenosis. J Heart Lung Transplant 2021, Volume 40, Issue 4, S529 – S530.
- J. Kanelidis, T. Miller, M. Belkin, U. Siddiqi, D. Rogers, N. Uriel, T. Song, T. Ota, S. Kalantari, N. Sarswat, A. Nguyen, B.B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Low Left Ventricular Stroke Work Index is Associated with a Poor Prognosis in LVAD Patients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S104.
- Hu, U. Siddiqi, J. Cruz, R. Hoang, A. Lee, M. Acosta, M. Dela Cruz, B. Smith, B. Chung, A. Nguyen, N. Sarswat, G. Kim, V. Jeevanandam, S. Pinney, J. Grinstein, S. Kalantari. Is VE/VCO2 Slope More Reflective of Isolated Cardiac Performance Compared to Peak VO2: A Comparison of Cardiopulmonary Stress Test Variables before and after Transplantation. J Heart Lung Transplant 2021, Volume 40, Issue 4, S216.
- Nazeer, J. Grinstein, S. Besser, S. Pinney, B. Chung. Management of Cardiac Sarcoidosis after Orthotopic Heart Transplant: A Multi-Institutional Experience. J Heart Lung Transplant 2021, Volume 40, Issue 4, S216.
- Dela Cruz, J. Grinstein, Y. Kumai, K. Hu, U. Siddiqi, B. Smith, G. Kim, N. Sarswat, A.B. Nguyen, B. Chung, S. Pinney, S. Kalantari. The Use of Cardiopulmonary Stress Testing to Predict Poor Outcomes Post-Heart Transplantation. J Heart Lung Transplant 2021, Volume 40, Issue 4, S217.
- K. Khush, K.B. Shah, A. Kao, S. Ghosh, L. Lourenco Jenkins, D. Baran, S. Pinney, S. Hall. Racial Disparities in Gene Expression Profiling but Not Donor-Derived Cell-Free DNA after Heart Transplant. J Heart Lung Transplant 2021, Volume 40, Issue 4, S218.
- B. Nguyen, B.B. Chung, S.A. Besser, A. Bennett, D. Rodgers, G. Kim, S. Pinney, N. Uriel, A. Aronsohn. Providers and Patients Differ in Their Opinions on Travel for Organ Transplantation. J Heart Lung Transplant 2021, Volume 40, Issue 4, S227.
- Dela Cruz, K. Terry, S.A. Besser, A.B. Nguyen, B. Chung, B. Smith, S. Kalantari, J. Grinstein, N. Sarswat, C. Murks, J. Powers, T. Riley, S. Pinney, G. Kim. Immune Function Testing and Long-Term Immune-Related Outcomes among Heart Transplant Recipients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S232.
- A. Siddiqi, M. Belkin, S. Kalantari, A. Kanelidis, T. Miller, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Combined Utility of Aortic Pulsatility Index and Pulmonary Artery Pulsatility Index for Risk Stratification in Advanced Heart Failure Patients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S247 – S248.
- R. Goldenberg, D. Rogers, V. Kagan, K. Meehan, J. Okray, S. Creighton, C. LaBuhn, T. Song, T. Ota, V. Jeevanandam, A.B. Nguyen, B. Chung, B. Smith, S. Kalantari, J. Grinstein, N. Sarswat, S.P. Pinney, G. Kim. Characteristics of LVAD Turn-Down Study to Predict Myocardial Recovery and Successful LVAD Decommissioning. J Heart Lung Transplant 2021, Volume 40, Issue 4, S249 – S250.
- Nishida, T. Song, D. Onsager, P. Combs, A. Nguyen, J. Grinstein, B. Chung, B. Smith, S. Kalantari, N. Sarswat, G. Kim, S. Pinney, V. Jeevanandam, T. Ota. Comparing Short/Long-Term Outcomes of Heart Transplants That Occur Inside and Outside of Normal Working Hours. J Heart Lung Transplant 2021, Volume 40, Issue 4, S261.
- A. Siddiqi, M. Belkin, S. Kalantari, A. Kanelidis, T. Miller, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Percent Increase in Aortic Pulsatility Index and Pulmonary Artery Pulsatility Index after Milrinone Infusion Predicts Escalation of Therapy and Mortality. J Heart Lung Transplant 2021, Volume 40, Issue 4, S261 – S262.
- A. Siddiqi, M. Belkin, S. Kalantari, A. Kanelidis, T. Miller, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Prognostic Role of Simultaneous Assessment of Biventricular Function Using Left Ventricular Stroke Work Index and Right Ventricular Stroke Work Index. J Heart Lung Transplant 2021, Volume 40, Issue 4, S262.
- A. Siddiqi, M. Belkin, S. Kalantari, A. Kanelidis, T. Miller, N. Sarswat, A. Nguyen, B. Chung, G. Kim, B. Smith, V. Jeevanandam, S. Pinney, J. Grinstein. Percent Increase in Left Ventricular Stroke Work Index and Right Ventricular Stroke Work Index after Milrinone Infusion Predicts Escalation of Therapy and Mortality. J Heart Lung Transplant 2021, Volume 40, Issue 4, S264.
- Smith, S. Kalantari, M. Belkin, B. Chung, A. Nguyen, G. Kim, S. Besser, N. Sarswat, V. Jeevanandam, S. Pinney, and J. Grinstein. The Effect of Race and Gender on Response to Milrinone and Time to LVAD or Transplant. J Heart Lung Transplant 2021, Volume 40, Issue 4, S282 – S283.
- N. Belkin, U. Siddiqi, F. Alenghat, A.B. Nguyen, B.B. Chung, B.A. Smith, S. Kalantari, N. Sarswat, G. Kim, S.P. Pinney, J. Grinstein. Combined Hemodynamic Measures of Left and Right Ventricular Function Predict Clinical Outcomes the ESCAPE Trial. J Heart Lung Transplant 2021, Volume 40, Issue 4, S285 – S286.
- A. Siddiqi, W. Cohen, J. Cruz, R. Hoang, P. Combs, S. Kalantari, B. Smith, B. Chung, A. Nguyen, N. Sarswat, G. Kim, V. Jeevanandam, S. Pinney, L. Lourenco Jenkins, J. Grinstein. Longitudinal Variation in Absolute and Relative AlloMap Score in Heart Transplant Recipients. J Heart Lung Transplant 2021, Volume 40, Issue 4, S297 – S298.
- Nishida H, Song T, Onsager D, Nguyen A, Grinstein J, Chung B, Smith B, Kalantari S, Sarswat N, Kim G, Pinney S, Jeevanandam V, Milner R, Ota T. Vasclar complications of percutaneous axillary intra-aortic balloon pump therapy. J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 642.
- Dela Cruz M, Littmann E, Nayak R, Lehmann C, Keskey R, Baker T, Lin H, Bennett A, Kim G, Pinney S, Pamer E, Nguyen AB. The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study. Am J Transplant 2021;21(Suppl 4):295.
- Cochran MK, Belkin MN, Siddiqui U, Nguyen A, Chung B, Smith B, Sarswat N, Kim GH, Pinney SP, Grinstein J, Kalantari S. A Comparison of Hemodynamic and Cardiopulmonary Exercise Stress Variables for Advanced Heart Failure Prognosis. Circulation 2021;144(Suppl_1).
- Prabhu N, Wali E, Stock W, Pinney S, DeCara Jm. Pulmonary vascular toxicity with tyrosine kinase inhibitor therapy: a rare case in a chronic myeloid leucemia patient. J Am Coll Cardiol CardioOnc. 2022 Mar, 4 (1_Supplement): S10.
- Kao, K. Khush, J.K. Patel, S.P. Pinney, N.Y. Raval, A. Luxon, K. Oreschak. Prevalence of Clinical Events Following High Donor Derived Cell Free DNA in the Absence of Rejection in Heart Transplant Recipients. J Heart Lung Transplant 2022;Volume 41, Issue 4, S440.
- DePasquale, K. Stribling, K. Shah, J. Zeng, W. Tian, K. Qu, N. Raval, P. Shah, S. Pinney. Is Absolute Change in AlloMap More Informative Than Absolute Value? J Heart Lung Transplant 2022;Volume 41, Issue 4, S443.
- J. Kanelidis, N. Prabhu, B. Smith, S. Kalantari, A. Nguyen, B.B. Chung, N. Sarswat, A. Shah, G.H. Kim, S.P. Pinney, J. Grinstein. Heart Mate 3 Pump Thrombosis After Ventricular Tachycardia Ablation: Pushing the Boundaries of Hemocompatibility. J Heart Lung Transplant 2022;Volume 41, Issue 4, S472 – S473.
- Alam, N. Uriel, K. Shah, P. Shah, J. Zeng, R. Dhingra, L. Bellumkonda, S. Pinney, E. DePasquale, S. Hall. Impact of Donor Characteristics on AlloSure Scores. J Heart Lung Transplant 2022;Volume 41, Issue 4, S337.
- E. Acosta, M.N. Belkin, P. Simone, V. Kagan, C. LaBuhn, K. Meehan, J. Okray, A.B. Nguyen, B.B. Chung, J. Grinstein, B.A. Smith, S. Kalantari, N. Sarswat, V. Jeevanandam, S.P. Pinney, G. Kim. Sodium Glucose Co-Transporter 2 Inhibitor Use in Patients with Left Ventricular Assist Devices. J Heart Lung Transplant 2022;Volume 41, Issue 4, S357 – S358.
- Pinney, M. Farr, C. Milano, A. Shah, J. Stehlik. Organ Care System Heart Perfusion Registry (OHP Registry) – Overview of a National Data Repository of Ex-Vivo Perfusion in DBD and DCD Heart Transplantation. J Heart Lung Transplant 2022;Volume 41, Issue 4, S363.
- Plana, A. Kanelidis, M.K. Cochran, W.F. Parker, V. Jeevanandam, C. Salerno, S. Kalantari, B. Smith, S. Pinney, J. Grinstein. Status Exception Use in the New Heart Allocation System: Identifying Inequalities in Allocation. J Heart Lung Transplant 2022;Volume 41, Issue 4, S195.
- J. Hoang, M. Acosta, N.F. Rasheed, J.M. Cruz, U. Siddiqi, S.V. Finn, S.E. Lupo, C.R. Stonebraker, Z. Li, K. Hu, D. Rodgers, C. Labuhn, S.P. Pinney, C. Salerno, V. Jeevanandam, J. Grinstein. Galectin-3 in Patients from 2012-2020: A Prognostic Biomarker of Left Ventricular Assist Device Post Implantation Outcomes. J Heart Lung Transplant 2022;Volume 41, Issue 4, S216.
- J. Hoang, N.F. Rasheed, M.E. Acosta, J.M. Cruz, U. Siddiqi, S.V. Finn, S.E. Lupo, C.R. Stonebraker, Z. Li, K. Hu, D. Rodgers, C. Labuhn, S.P. Pinney, C. Salerno, V. Jeevanandam, J. Grinstein. Racial and Gender Disparities in the Prognostic Value of Galectin-3 in Post Left Ventricular Assist Device Outcomes. J Heart Lung Transplant 2022;Volume 41, Issue 4, Issue 4, S216.
- N. Belkin, B.A. Smith, S. Kalantari, B. Cody, A.B. Nguyen, J. Grinstein, B.B. Chung, D. Rodgers, Z. Li, N. Sarswat, G. Kim, S.P. Pinney. The Sleeping Giant Awakes: A Case of Recurrent Post-Transplant Giant Cell Myocarditis. J Heart Lung Transplant 2022; Volume 41, Issue 4, S226.
- Nishida, V. Jeevanandam, C. Salerno, T. Song, D. Onsager, A. Nguyen, J. Grinstein, B. Chung, B. Smith, S. Kalantari, N. Sarswat, G. Kim, S. Pinney, T. Ota. Early and Long-Term Outcomes of the Prophylactic Tricuspid Annuloplasty in Heart Transplantation. J Heart Lung Transplant 2022;Volume 41, Issue 4, S241 – S242.
- Plana, U. Siddiqi, M.N. Belkin, A. Nguyen, B.B. Chung, D. Rodgers, Z. Li, J. Grinstein, S. Kalantari, N. Sarswat, G. Kim, S.P. Pinney, B. Smith. The Effect of Race on Heart Transplant Outcomes by Age. J Heart Lung Transplant 2022;Volume 41, Issue 4, S80.
- Teuteberg, S. Pinney, K.K. Khush, M. Fei, M. Zhou, S.R. Patel, M. K. Kanwar, K. Shah, P. Shah, N. Uriel. Should We Be Comforted by a “Negative” Endomyocardial Biopsy? Risk of Future Events with Donor Derived Cell Free DNA in the Setting of Histologic Quiescence. J Heart Lung Transplant 2022;Volume 41, Issue 4, S115.
- Rao, M. Kanwar, D.A. Baran, W. Tian, U.P. Jorde, S. Pinney, E. DePasquale, K. Shah, P. Kim, J. Teuteberg, N. Uriel. Prognostic Implications and Characteristics of Low dd-cfDNA Results in Heart Transplant Patients with Biopsy Proven Rejection. J Heart Lung Transplant 2022;Volume 41, Issue 4, S115.
- Uriel, S. Hall, U.P. Jorde, S.R. Patel, S. Pinney, W. Tian, D.A. Baran, E. DePasquale, P. Kim, A. Kao, N. Raval, J. Teuteberg, G.T. Sayer. Effect of CMV Viremia on HeartCare. J Heart Lung Transplant 2022;Volume 41, Issue 4, S118.
- Kanwar, F.D. Pagani, J.D. Estep, S.P. Pinney, S.C. Silvestry, N. Uriel, D.J. Goldstein, M.R. Mehra, J.C. Cleveland, R.L. Kormos, A. Wang, J. Chuang, J.A. Cowger. Variability Across Implanting Centers in Short and Long-Term Mortality and Adverse Events in Patients on HeartMate 3 Support: A Momentum 3 Secondary Analysis. J Heart Lung Transplant 2022;Volume 41, Issue 4, S120.
- Dela Cruz, H. Lin, E. Adler, M. Khalid, J. Boissiere, G. Kim, S. Pinney, E. Pamer, A. Nguyen. The Gut Microbiome as a Marker of Early Cardiac Allograft Injury. J Heart Lung Transplant 2022;Volume 41, Issue 4, S122.
- Dela Cruz, H. Lin, E. Adler, R. Lavelle, A. Loethen, M. Khalid, J. Boissiere, G. Kim, S. Pinney, E. Pamer, and A.B. Nguyen. The Gut Microbiome and Tacrolimus Dosing in the Peri-Heart Transplant Period. J Heart Lung Transplant 2022;Volume 41, Issue 4, S122.
- A. Siddiqi, M.N. Belkin, G. Li, R. Hoang, K. Hu, V. Jeevanandam, S. Pinney. Panel-Reactive Antibody Associated with Acute Rejection Episodes After Heart Transplantation: An Analysis of the UNOS Database. J Heart Lung Transplant 2022; Volume 41, Issue 4, S129.
- McCarthy, E. Molina, H. Nemeh, S. Chaudhry, S. Pinney, A. Srivastava, J. Grinstein, I. Hackett, J.A. Cowger. Characterizing Outflow Graft Narrowing over Time. J Heart Lung Transplant 2022;Volume 41, Issue 4, S138.
- N. Belkin, U. Siddiqi, S. Kalantari, A.J. Kanelidis, T. Miller, A.B. Nguyen, B.B. Chung, D. Rodgers, Z. Li, B.A. Smith, N. Sarswat, G. Kim, S.P. Pinney, J. Grinstein. Accuracy of Estimated versus Calculated Mean Pulmonary Arterial Pressure. J Heart Lung Transplant 2022;Volume 41, Issue 4, S317 – S318.
Scholarly Contributions and Creative Productions/Scholarship in the Area of Education:
- Healthology.com
http://www.netsurgery.com/faculty_bio.asp?b=healthology&d=pinney_sean
“Drug treatment of essential hypertension”
“Exercise stress testing”
Last accessed on 11/26/2008
- Quantiamd: Interactive Physician Community
http://www.quantiamd.com/player/iykevwi?
“Decompensated Heart Failure Therapy – (Parts 1 through 5)”
Last accessed on 11/26/2008
- Faculty of 1000: F1000 Prime
http://f1000.com/prime/thefaculty/member/499999771097515596
Last accessed on 3/22/2014
- AST Timely Topics in Transplantation Webinar: Novel immunosuppressants: applicability to organ transplantation. Role: moderator. Speaker: Jon Kobashigawa, MD. https://www.myast.org/education/webinars/novel-immunosuppressants-applicability-thoracic-organ-transplantation
Last accessed: November 14, 2017
- AST Power2Save: Getting a new heart
https://power2save.org/wp-content/uploads/2019/01/15_AST-18-EB-Getting-a-new-heart_FINAL.pdf
Last accessed on 01/31/2019
- Abbott National Webinar
COVID 19 & Heart Failure: Current Perspective for Patient Management
Last accessed 4/7/2020
- Abbott Asia International Webinar
Peer to Peer Webinar: COVID 19 & Heart Failure: Current Perspective for Patient Management. https://event.on24.com/wcc/a/2265385/27877D369A6D62A587A80094A9A0E5AB?partnerref=on24seo
Accessed 4/10/2020
- American College of Cardiology (ACC.org)
Frontline perspectives: COVID-19 in New York City
Accessed 4/11/2020
- Boston Scientific Educare
Patient management with remote monitoring during COVID-19.
https://gateway.on24.com/wcc/eh/2158631/On+Demand+Training
Delivered 9/15/2020
- ACCEL Interview
New approaches to treating cardiorenal syndrome
Interviewee: Dr. Jennifer Cowger
10/16/2020
- ACCEL Interview
Conversations in Cardiology: Exercise Right Heart Catheterization
Interviewees: Dr. Donna Mancini and Dr. Paul Forfia
12/3/2020
- ACCEL Interview
New Medical Therapies for Hypertrophic Cardiomyopathy
Interviewee: John J. Ryan, MD
4/1/2021
- ACCEL Interview
Strategies to Maximize Doses and Introduce New Medication
Interviewee: Brad Williams, PharmD
5/25/2021
- ACCEL Interview
ACC.21 Late Breaker: Sacubitril/Valsartan in Patients with Advanced Heart Failure and Reduced Ejection Fraction: Results of the Life Trial
Interviewee: Douglas L. Mann, MD
6/1/2021
- HFSAP Editor
Creation and review of Self-Assessment Questions in Advanced Heart Failure and Transplant Cardiology for the American College of Cardiology’s Heart Failure Self-Assessment Program (HFSAP).
January 2019 – ongoing
Community Service:
Harlem Heart Health Series
February 2015 “Heart Failure Education: Salt restriction for Heart Failure and Hypertension”